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ABSTRACT

Transposon mutagenesis facilitates discovery of genotype-phenotype associations and functional
interrogation of the Mycobacterium kansasii genome
by
William Chase Budell

Advisor: Dr. Luis E.N. Quadri

Mycobacterium kansasii (Mk) is a nontuberculous mycobacterium (NTM) and medically
relevant opportunistic human pathogen. Mk causes dangerous disease pathologies ranging from
tuberculosis-like chronic pulmonary disease (CPD) to non-pulmonary focal or disseminated
infections that are exacerbated by comorbidities such as chronic obstructive pulmonary disease
(COPD), co-infection with HIV, or cancer. Among the most frequently identified cause of NTMlinked CPD, Mk infections contribute to a globally increasing NTM disease burden and are
difficult to treat, requiring a long-term, multi-drug regimen. Although a less virulent pathogen
than Mycobacterium tuberculosis (Mtb), Mk elicits similar disease features and shares in vitro
growth characteristics with the ‘tubercle bacillus’. Due to a high level of genetic similarity and
lower biosafety concern, Mk also has potential as an attractive model organism for the study of
Mtb. Despite this, research into Mk gene function is limited and no genome-wide studies have
been reported. Here, we provide evidence that demonstrates the functionality of a phage-based
transposon (Tn) mutagenesis system in Mk by generating and screening a library of random
insertion mutants for altered macrocolony morphology. In this screen, we identified 41 mutants
exhibiting unique phenotypes, among them one carrying disruption to a gene encoding a
conserved mycobacterial small regulatory RNA for which we established a previously
iv

unrecognized role in (macro)colony morphology and biofilm formation. Additionally, we
showed Galleria mellonella larva are susceptible to Mk infection, demonstrating the potential of
this increasingly popular infection model for the study of Mk pathogenicity and efficacy of
antimicrobial compounds. Finally, we combined Tn mutagenesis with next generation
sequencing to identify 12,071 unique insertion sites that do not impact Mk viability. A
comparison of our results to published transposon sequencing data for Mtb identified 11 Mk
orthologs of essential Mtb genes tolerant of transposon insertion that potentially reflect
significant differences in genetic requirements between the two species. Together, this work
demonstrates Tn mutagenesis is an effective tool to study gene function in Mk and sets the stage
for more comprehensive comparative genetic studies of Mk and Mtb.
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CHAPTER 1: INTRODUCTION

1.1 Nontuberculous mycobacteria
The broad category of nontuberculous mycobacteria (NTM) includes over 150 identified
pathogenic and non-pathogenic species and is typically organized into four groups according to
growth rate and production of carotenoid pigment. Colonies of slow-growing mycobacteria
(SGM) take longer than seven days to develop and produce pigment only in response to light
(Type I: photochromogens), constitutively (Type II: scotochromogens), or not at all (Type III:
nonphotochromogens). Type IV NTM include the rapidly growing mycobacteria (RGM) that
develop colonies in less than seven days (Table 1). Distinct from members of Mycobacterium
tuberculosis (Mtb) complex including the causative agent of human tuberculosis and M. leprae,
the causative agent of leprosy, NTM are environmental in origin and opportunistically infect
healthy or immunocompromised individuals. Although non-pulmonary infections such as
abscesses and focal lesions on various organs occur, pulmonary infections are the most
frequently encountered and often lead to chronic pulmonary disease (CPD). Common symptoms
of NTM CPD such as chronic cough, coughing blood (hemoptysis), fatigue, and weight loss
mirror those of traditional tuberculosis. Often, NTM infections in patients with comorbidities
such as smoking, co-infection with HIV, or cancer progress to disseminated infections in
multiple organs.1,2
Despite the difficulty of determining the true prevalence of clinical NTM cases due to a
lack of mandatory reporting in most regions, they appear to be increasing in most regions
examined.3,4 Although the relative frequency of detected infections by different NTM species
varies based on factors such as local environmental and population characteristics, the species
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most frequently associated with disease include those belonging to the M. avium and M.
abscessus complexes and M. kansasii (Mk).5

Table 1: Classification of the nontuberculous mycobacteria

Runyon
classification
group

Growth

Type I
Type II

slow-grower
(>7 days)

Type III
Type IV

rapid grower
(<7 days)

Pigmentation

Representative species

light induced
(photochromogen)

M. kansasii, M. marinum, M. simiae

constituitive
(scotochromogen)

M. gordonae, M. scrofulaceum, M.
szulgai, M. flavescens

absent
(nonchromogen)

M. avium, M. ulcerans, M. terrae, M.
xenopi, M. haemophilum

undetermined
(generally absent)

M. abscessus complex, M. fortuitum,
M. chelonae, M. smegmatis

Adapted from (1,6)

1.2 Mycobacterium kansasii
Mk is a relatively understudied NTM species first identified in 1953 by Buhler and Pollak
as an atypical mycobacterium they termed the ”yellow bacillus”.7 Isolated from clinical samples,
Mk did not display the culture characteristics of Mtb but was determined to be the causative
agent of a tuberculosis-like pulmonary infection and lymphadenitis in two separate patients,
respectively. Mk is somewhat distinct from other NTM in that it is most often found associated
with faucet taps and in water from municipal water systems rather than soil.8 Enabling this
association is the ability of Mk, shared with other NTM, to form tenacious biofilms, communities
of one or more bacterial species that form at the air-surface interface or on the submerged surface
of a solid material. Biofilms are characterized by both dormant and replicating cells residing in a
secreted matrix composed of extracellular polymeric substances (EPS) including
2

polysaccharides, proteins, and lipids.9,10 The establishment of a biofilm enables persistence in the
environment by endowing a bacterium the ability to survive and grow in the face of low pH, low
nutrient availability, and temperature fluctuations. This resilience coupled with the slow growth
rate of Mk and other NTM contributes to a high level of resistance to disinfectants exhibited by
biofilm-associated cells and makes the pathogen reservoirs that biofilms represent difficult to
eradicate.
The existence of these pathogen reservoirs and little evidence of person-person
transmission, supports the assertion that infections are environmentally acquired.11 Opportunistic
pathogens such as Mk, M. avium, and M. fortuitum often enter a human host following dispersal
from a biofilm. Substrates identified that harbor biofilms leading to infection include
showerheads, water heaters, water distribution pipes, and medical devices such as catheters,
aortic valves, or breast implants.9 Although the ability to form a biofilm is not predictive of
virulence (the nonpathogenic M. smegmatis [Ms] readily forms biofilms), biofilm-associated
cells have been shown to be many times more resistant to disinfectants and antimicrobials than
their genetically identical planktonic counterparts.12 This resistance is thought to be the result of
multiple factors: one, secreted EPS that reduces exposure of biofilm-embedded cells to
antibacterial compounds; two, a population of so-called persister cells that are non-replicative
and/or exhibit a state of severely reduced metabolic activity; and three, the occurrence of
horizontal gene transfer between tightly packed cells leading to the transfer of beneficial
mutations between biofilm residents.9,10 In addition to the biofilms formed by NTM in the
environment, evidence suggests several mycobacterial species including M. avium, M. abscessus,
and M. ulcerans are able to form in vivo biofilms that are thought to contribute to the
recalcitrance of infections with these pathogens to treatment.10
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Common routes of Mk infection include trauma, accidental inoculation, or inhalation of
an aerosolized sample. As with other opportunistic NTM pathogens, individuals exhibiting
structural pulmonary damage, such as that arising from chronic obstructive pulmonary disease
(COPD), bronchiectasis, prior Mtb infection, or pneumoconiosis (“black lung disease”) are at
increased risk of infection. In addition, both heritable (i.e. impaired production of or response to
cytokine signaling; lymphocytopenia) and non-heritable (i.e. use of TNF-α antagonists, organ
transplant, AIDS) risk factors predisposing individuals to infection have been identified and
frequently involve immune dysfunction.13-16 Indeed, Mk is the second-most prevalent NTM
species after M. avium identified in respiratory samples of patients suffering from AIDS and is
often considered the most virulent NTM as positive detection in a patient sample is generally
associated with active disease rather than colonization.8 In a 2013 study, Mk was found to be the
most frequently isolated NTM in Slovakia and Poland at 36% and 35%, respectively, and sixth
most frequently isolated species overall.17 Despite this recognized impact on human health, only
four papers report experimental findings that directly interrogate gene function in Mk.18-21

1.3 M. kansasii as pathogen and M. tuberculosis model organism
The symptoms and disease pathologies that characterize Mk infection mirror and are
often indistinguishable from those of active tuberculosis. Those suffering from infections of
either Mk or Mtb will often both present with longstanding, generalized symptoms such as
cough, chest pain, difficulty breathing and similar radiological findings.2 For example, both
pathogens elicit the development of pulmonary fibrocavitary lesions seen on thoracic
radiographs. These lesions, air-filled spaces often surrounded by a thickened wall, are generally
found in the upper lobes of the lung and result from caseous necrosis, a process instigated by the
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host immune response that greatly assists dissemination of the pathogen.22 However, Mk
infections are generally effectively treated with the first-line anti-Mtb drugs isoniazid, rifampin,
ethambutol, and pyrazinaminde with rates of resistance lower than for Mtb.
The difficulty working with Mtb arising from its slow growth rate and elevated biosafety
concerns has driven many TB researchers to use the closely related M. marinum (Mm) as a
surrogate in experimental work. Mm causes granulomatous disease in fish and amphibians
similar to that of active tuberculosis as well as dermal lesions in humans that resemble those seen
with Mtb infections. Mm is genetically tractable, has a considerably reduced in vitro doubling
time of 4-5 hours compared to over 20 hours for Mtb, and can be manipulated under Biosafety
Level 2 containment.23 However, the restriction of Mm infections to the epidermis and dermis of
mammalian hosts that is attributable primarily to its poor growth at 37°C presents a clear
disadvantage as a true stand-in for modeling Mtb disease of humans.
As an alternative model Mtb organism, Mk presents several advantages, including a
similar optimal growth temperature (37°C), doubling time, and ability to cause pulmonary and
disseminated infections in humans and other mammals. Although 16S rRNA sequencing
identified high sequence similarity between Mm and Mtb, a more global comparison of shared
genes indicate Mk is the closer relative.24 A recent comparative study of the 6.4 Mb Mk genome
and the much-reduced 4.4 Mb Mtb genome demonstrated significant sequence similarity and
synteny despite the two species’ drastically different levels of pathogenicity.25 Notably, several
recognized Mtb virulence factors are present in Mk.25,26 These similarities in addition to its
recognition as a significant cause of NTM disease suggest the study of Mk both as an alternative
model of Mtb and as a bona fide human pathogen is warranted.
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1.4 Transposon mutagenesis rationale
Aside from the recent publication of the first targeted Mk mutant,21 the existing literature
pertaining to Mk deals with studies of microbiological, clinical, or epidemiological aspects rather
than direct genetic manipulation of the bacterium. Invaluable tools in the genetic investigation of
medically significant organisms such as Mk are libraries consisting of thousands of mutants that
carry random genomic mutations. In the past 20 years, transposons of eukaryotic origin designed
to stably integrate into prokaryotic genomes with low site-specificity have been utilized with
great success to generate such mutant libraries in Mycobacteria.27-29 Advantages of transposonmediated insertional mutagenesis (Tn mutagenesis) techniques over those employing either UV
irradiation or a chemical mutagen include: the ability to co-deliver a selection marker with the
gene-disrupting transposon that allows insertion mutants to be readily identified; relatively easy
insertion site identification via PCR amplification using the known transposon sequence as a
guide; the avoidance of multiple mutations of a single genome by effectively deactivating further
transposition following a single insertion.30 Constructs utilized for Tn mutagenesis are
characterized by two components: the insertional element itself (the transposon) and a delivery
vector. Although suicide (non-replicative) plasmids can be used to deliver the mutagenizing
transposon, slow-growing mycobacterial species are characteristically difficult to transform. A
more efficient delivery vehicle is a conditionally replicative mycobacteriophage that can
potentially infect and transduce every cell in a culture but is unable to replicate and lyse host
cells at a restrictive temperature. To obtain such a phage, Bardarov et al.31 exposed the naturally
occurring mycobacteriophage, TM4, to hydroxylamine and selected a clone (PH101) that was
lytic in Ms at 30°C, but not at 37°C. They inserted a cosmid vector containing the mutagenizing
transposon into a nonessential region of the PH101 genome to generate phAE87, a so-called
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“phasmid” (phage + cosmid), that they successfully used to mutagenize the SGM species M.
bovis BCG and Mtb. Several other groups have employed similar conditionally replicative
phasmids to generate transposon mutant libraries of various sizes in multiple mycobacterial
species, but such work has not yet been reported in Mk.

1.5 Origin & description of φMycoMarT7 phasmid
For our study, we employed a conditionally replicating transposon delivery shuttle
phasmid, φMyoMarT7, constructed by Sassetti et al.32 from phAE87 and generously supplied by
the Rubin Lab and the Harvard School of Public Health. φMycoMarT7 carries a modified
version of the magellan4 transposon from the pMycoMar27 plasmid that contains a Km
resistance cassette (for selection of transductants) and the oriR6Kγ E. coli origin of replication
(allowing plasmid replication for genetic manipulation within pir+ E. coli, and ensuring plasmid
loss following transposition in pir- E. coli.). Unlike in pHAE87, these elements in φMycoMarT7
are flanked by 29 bp inverted repeat sequences that are recognized by a highly active
transposase, C9 Himar1, encoded by a gene placed outside of the inverted repeats and under the
control of a T6 promoter that is active in Mycobacteria but not E. coli. This approach prevents
transposition in E. coli, but enables transposition in the absence of lysis in mycobacteria when
infected at the restrictive temperature of 37°C. Finally, to facilitate TraSH (transposon site
hybridization), a technique Sassetti et al. developed to enable high throughput mapping of
insertion sites in pools of transposon mutants, outward-facing T7 promoters were included just
inside the Himar1 repeat sequences.
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1.6 Colony morphology screening as a tool to reveal perturbations to the cell wall, a key
factor in mycobacterial virulence

Mediating the uptake and survival of any pathogenic mycobacterium in a host is its cell
envelope, an unusually complex, multilayered structure composed of three primary sections: the
plasma membrane, the cell wall core or mAGP (mycolyl-arabinogalactan-peptidoglycan)
complex, and an outermost, capsule-like layer (Figure 1).33 Although the composition of the
envelopes of different species vary, all are characterized by ultra-low permeability due in no
small part to the mycolic acid (mycolate) layer of the mAGP. Mycolic acids are extremely long
chain (>C70), highly saturated fatty acids that endow the mycobacterial cell with both high
hydrophobicity and low fluidity, even at elevated temperatures, and help create a highly
impermeable barrier.34,35 To the mycolate layer, the outermost covalently bound layer, are
attached noncovalently bound lipids and glycolipids. Phosphatidylinositol mannosides (PIM),
lipomannan (LM), lipoarabinomannan (LAM), lipooligosaccharides (LOS), and phenolic
glycolipids (PGL) are examples of such lipids that have been implicated in such wide-ranging
aspects of virulence as cellular adhesion, interference with phagosomal maturation, and
macrophage activation.36-38
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Figure 1: Generalized model of the mycobacterial cell envelope
Image from Daffe et al.33 with additional information from Kaur et al.39 and Tran et al.38

Additionally, as many of these lipids contribute to physical characteristics of the cell wall
such as hydrophobicity, permeability, and integrity, mutants with altered levels of one or more of
these outer membrane components have been identified based on colony appearance. Indeed,
colony morphology has repeatedly been associated with phenotypic characteristics either directly
(resistance to antibiotics,40 host/cell infection or intracellular replication,41-43 host-killing 44) or
indirectly (cell surface hydrophobicity,45-47 sliding motility,48,49 biofilm formation40,50) related to
bacterial pathogenicity.
The clear association between colony morphology and the make-up of the mycobacterial
cell envelope underpins the idea that screens for altered colony morphology performed on
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libraries of transposon mutants generated in a bacterial species of interest are a robust and
efficient strategy for the identification and assignment of function to uncharacterized genes. We
hypothesize that such a screen in Mk will identify a pool of mutants enriched for mutations in
genes relating to cell well and that these mutations will impact other virulence associated
phenotypes.

1.7 Research objectives
The use of phage-mediated Tn mutagenesis in the study of mycobacteria is not new and
has been applied to both pathogenic and nonpathogenic species. In the current study, we sought
to demonstrate for the first time the functionality of this robust genetic tool to study the biology
of Mk, a clinically relevant but understudied pathogen of humans. The work reported in this
dissertation aims to:
I.
II.

Determine whether the φMycoMarT7 phasmid is an effective mutagenic tool in Mk
Provide proof of principle that Tn mutagenesis is a feasible method to study gene
function in Mk by:
a. performing a forward genetic screen of random transposon-insertion mutants to
identify those with disruptions to cell wall-related genetic elements involved in
virulence-associated traits.
b. utilizing next generation, high throughput sequencing to determine en masse
transposon insertion sites in a pool of several thousand library mutants to
interrogate the annotated Mk genome
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CHAPTER 2: Assessment of φMycoMarT7 functionality in M. kansasii

2.1 INTRODUCTION
Tn mutagenesis has been performed in both slow-growing (Mtb, M. bovis BCG,31,32 M.
ulcerans,51 Mm,41,52,53 M. avium subsp. paratuberculosis,54 M. avium 55) and fast-growing
(Ms,32,40,56 M. fortuitum,32 M. phlei 31) mycobacteria using transduction with conditionally
replicating phasmids. Such work has not only identified specific mycobacterial genes involved in
virulence associated traits such as cording,57 siderophore biosynthesis,58 outer membrane lipid
production,44,53 and intracellular replication44,59 but also genes essential for growth under various
conditions.32,60-62
To our knowledge, there are no reports of the use of Tn mutagenesis in Mk and we aimed
to demonstrate the potential of using φMycoMarT7 to explore the biology of this human
pathogen. Although used with success to generate mutant libraries in multiple mycobacteria,
TM4-based phasmids have demonstrated species specificity. For instance, although a TM4derived, GFP-reporter phage was unable to lyse either of the closely related RGM species M.
abscessus or M. massiliense, post-exposure fluorescence (indicating an ability of phage particles
to attach and deliver DNA) was observed only with M. massiliense.63 In light of such evidence,
we felt it pertinent to validate the functionality of φMycoMarT7 in Mk prior to employing it to
generate a library of transposon mutants. As a first step, we isolated a phage clone from our
original sample and confirmed its temperature sensitive phenotype. Next, we demonstrated the
phage was able to lyse Mk, albeit at a rate roughly 1,000-fold less than that of Ms and that lysis
was temperature dependent. We then showed that φMycoMarT7 is competent to transduce Mk in
a dose-dependent manner leading to the successful integration of the Himar1 transposon as
indicated by the consistent recovery of kanamycin-resistant (Kmr) colonies on selective medium.
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We feel this work sets the stage for the use of this powerful and effective transposon delivery
system to generate random insertion mutants and allow the interrogation of Mk on a genomewide scale as has been demonstrated in Mtb.64

2.2 MATERIALS AND METHODS

2.2.1 φMycoMarT7 phasmid stock generation
Bacterial strains and culturing conditions
Ms strain mc2155 (ATCC 700084) was used for all propagation and enumeration of phage stock
titers. Frozen concentrated Ms stocks were diluted 1:1000 in Middlebrook 7H9 media (Difco)
supplemented with 10% ADN (5% BSA, 2% dextrose, 0.85% NaCl), 0.05% Tween-80, and
0.2% glycerol (supplemented 7H9) and grown overnight at 37°C with 220 RPM orbital shaking
to stationary phase. 30 µg/ml kanamycin (Km) was added where appropriate (supplemented
7H9-Km). Culture aliquots (500 µl) used for phage infection were washed twice and resuspended
in supplemented 7H9 lacking Tween-80 (phage buffer: PB). Frozen concentrated stocks of Mk
(ATCC 12478) were diluted 1:500 in 5 ml supplemented 7H9 containing 5-10 sterile, 3 mm glass
beads and grown 7-8 days at 37°C without supplemental light and with 170 RPM orbital shaking
(standard conditions). Cultures used for infection were washed twice then concentrated 10-fold
in PB pre-warmed to 37°C.

Isolation of a temperature sensitive phage clone and generation of a high titer stock
100 µl aliquots of washed Ms cells were combined with 3.5 ml top agar at 42°C, poured onto LB
agar plates, and allowed to dry. Several well-isolated plaques selected from titering plates of the
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original Rubin Lab phage stock (see below for general phage titering protocol) were patched
onto duplicate LB agar plates and incubated at 30°C (permissive temperature) or 37°C
(restrictive temperature) for 48 hours. Temperature sensitive clones develop plaques at 30°C at
locations matching

30°C

37°C

Figure 2: Calculation of φMycoMarT7 clone temperature sensitivity
100 µl of Ms cells were infected with 10 µl of 10-fold serial dilutions of the temperature sensitive phage
clone, added to top agar plates, incubated at 30°C and 37°C for 48-72 hours, and developed plaques were
counted.

those where no plaques developed at 37°C. To confirm the temperature sensitivity and generate a
concentrated stock of a selected clone, a sterile toothpick was used to excise the agar beneath the
plaque and crush in 250 µl PB buffer. After centrifugation for 1 minute at 15,000 RPM, the
supernatant was collected and stored as an undiluted stock of the clone. Duplicate sets of Ms
13

infection plates were prepared as above with 10-fold serial dilutions of the phage clone stock to
be tested and placed at 30°C and 37°C for 48 hours. Determination of the percentage of the stock
that was temperature sensitive was made by dividing the titer calculated from plaques that
developed at the restrictive temperature by the titer calculated from plaques that developed at the
permissive temperature (Figure 2).
To generate a high titer stock for infection, the dilution of the temperature sensitive clone
stock that resulted in nearly confluent (“lacy”) plaques on the Ms titering plate was selected. 10
µl aliquots of this dilution were used to infect 100 µl aliquots of washed Ms cells, mixed with 3.5
ml top agar, poured onto Middlebrook 7H10 agar plates, and incubated at 37°C. After 48 hrs, the
plates were flooded with 2 ml PB and gently rocked at 4°C overnight (16 hours). Phage were
recovered the next day by filtering the liquid remaining on the plates through a 0.22 µm filter
directly into microcentrifuge tubes for storage at 4°C. A final titer of the new stock was
calculated as described below.
To determine the titer of the high phage stock, 100 µl aliquots of washed Ms cells were
combined with 10 µl (8) 10-fold serial dilutions of a phage stock and added to 3.5 ml top agar
kept at 42°C. Mixtures were poured onto the surfaces of pre-dried, LB agar (VWR) plates,
allowed to cool, and incubated at 37°C for 48 hours. Phage titer in plaque-forming units per
milliliter (pfu/ml) was determined from plates containing a countable number of developed
plaques using the formula:
pfu
1000 μl ∙ number of plaques
= phage titer ൬ ൰
ml
volume plated ሺμlሻ ∙ dilution
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2.2.2 Spot inoculations of φMycoMarT7 on mycobacterial lawns
2.5 ml starter cultures of Ms and Mk were inoculated from concentrated frozen stocks and
grown for 24 and 48 hours, respectively (culturing conditions as above). These cultures were
then used to inoculate 45 ml daughter cultures that were grown for 1 (Ms) or 3 (Mk) additional
days to OD 1. Both cultures were then washed twice with PB and concentrated to OD 2. The
density of each cell suspension was confirmed spectrophotometrically. Lawns of both species
were prepared as above by mixing aliquots of cell suspensions with top agar at 42°C, pouring
onto pre-warmed LB agar plates, and allowing to solidify. 10 µl of 10-fold serial dilutions
(undiluted through 10-9) of a confirmed temperature sensitive phage clone in PB were spotted
onto duplicate lawns, allowed to dry, then incubated at 30°C and 37°C for 3 (Ms) or 8 (Mk) days.
Plates were imaged for determination of phage titer.

2.2.3 Comparison of transposon mutant generation at multiple MOI
Dilute phage were added to an aliquot of washed, 10X concentrated Mk cells in PB at
relative volumes not exceeding 2:5 to a pre-determined MOI (multiplicity of infection, phage:
bacteria). The infection was placed at 37°C without shaking for 4 hours. Mock controls were
prepared by adding phage-free PB to Mk cells. After incubation, 50 µl aliquots of 10-fold serial
dilutions of the phage infection or mock mixtures were plated on supplemented Middlebrook
7H10 agar with or without 30 µg/ml Km and placed in a humidified incubator at 37°C for 14
days. Glycerol was added to 10% to any remaining infection mixtures that were then stored at
-80°C. Incubated plates were intermittently examined and upon full colony development, were
imaged and then stored at 4°C until colony picking.
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To determine the rate of transduction by the φMycoMarT7 phasmid in Mk, colony counts
were made of transduced (Km-containing plates) and total (drug-free plates) cells and compared.
Loss of viability resulting from infection was determined by comparing phage-exposed to
unexposed (mock-infected) cells on drug free plates. (See Figure 3 for example calculation of
transduction efficiency.)

After plating 50 µl of each indicated dilution of infection mixtures, colony counts reveal:
•

•

•

•

pMMT7-infected, 7H10a/kan30b:
o 10-1 → 142; 142/(0.1) (0.05)
= 2.8 x 104 cfu/ml
-2
o 10 →8;
8/(0.01) (0.05)
= 1.6 x 104 cfu/ml
-3
o 10 → 2;
2/(0.001) (0.05)
= 4.0 x 104 cfu/ml
o Average:
= 2.8 x 104 cfu/ml
pMMT7-infected, 7H10:
o 10-5 → 155; 155/(10-5)(0.05) = 3.1 x 108 cfu/ml
o 10-6 → 33;
33/(10-6)(0.05)
= 6.6 x 108 cfu/ml
-7
-7
o 10 → 1;
1/(10 )(0.05)
= 2.0 x 108 cfu/ml
o Average:
= 3.9 x 108 cfu/ml
Mock-infected, 7H10/kan30
o 10-1 → 0
o 10-2 → 0
o 10-3 → 0
Mock-infected, 7H10
o 10-5 → 149; 149/(10-5)(0.05) = 3.0 x 108 cfu/ml
o 10-6 → 21;
21/(10-6)(0.05)
= 4.2 x 108 cfu/ml
-7
-7
o 10 → 3;
3/(10 )(0.05)
= 6.0 x 108 cfu/ml
o Average:
= 4.4 x 108 cfu/ml

In this case,
• Minimal to no loss in Mk viability is detected (3.9 x 108 vs 4.4 x 108 cfu/ml)
• No spontaneous mutants were detected (no growth of mock-infected on Km plates)
• The transduction/transposition efficiency is:
(2.8 x 104)/(3.9 x 108) = 1/x; x = 1.39 x 104
or:
1:13,900

Ratio of cells that have received the transposon and become
Km resistant to all phage-exposed cells

Figure 3: Example calculation of phage transduction efficiency
a

Middlebrook 7H10 agar; b kanamycin 30 µg/ml present in agar medium
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2.3 RESULTS

φMycoMarT7 efficiently lyses M. kansasii lawns
We determined the initial φMycoMarT7 phage stock provided by the Rubin Lab to be
90.909% temperature sensitive after extended storage at the recommended temperature of 4°C.
Three successive rounds of selection resulted in a phage stock that demonstrated 99.778%,
99.905%, and 99.978% temperature sensitivity, respectively, and we generated a high titer (9 x
1010 pfu/ml) stock of a clone from the final selection round to use for Mk infections. We also
determined a titer of ~108 pfu/ml of the initial Rubin Lab stock, roughly 1000-fold lower than
had been reported for the stock, indicative of a noticeable loss of viability. Although it is
tempting to posit a correlation between the loss of phage viability and temperature sensitivity and
speculate as to the factors causing each, evidence for such a correlation has not been shown and
the inclusion of a temperature sensitive clone re-isolation step in the published φMycoMarT7
protocol30 suggests both are a recognized phenomenon.
Spotting serial dilutions of the selected φMycoMarT7 clone onto Mk and Ms lawns
showed that when incubated at the permissive temperature (30°C), Mk is approximately 1,000fold less susceptible to phage lysis than Ms (Figure 4). Somewhat unexpectedly, duplicate lawns
incubated at the restrictive temperature (37°C) showed noticeable clearing where exposed to
undiluted and 10-fold diluted phage. We believe this clearing is explained by two factors
independent of the partial reversion of the phage stock to a temperature insensitive phenotype.
First, although Mk and Ms lawns were prepared on plates pre-warmed to 37°C, phage aliquots
were spotted and allowed to dry in a room temperature (22-25°C) biosafety cabinet (BSC) for
several minutes, leading to a transient cooling of the plate prior to replacement at 37°C. Second,
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the high number of pfu (approx. 1010 and 109 pfu, respectively) in the droplets of undiluted and
10-fold diluted phage added to the bacterial lawns led to a relatively high concentration of
individual lytic events permitted by the less restrictive temperature within the BSC. This
transient lysis, halted after we moved the plates to 37°C, effectively reduced bacterial density at
the spot locations and led to partial, but observable, thinning of the lawn following outgrowth. In
addition, although the clearings on Ms lawns at the permissive temperature appeared devoid of
any cellular growth, all Mk clearings were turbid or hazy, typical of lysogenic or temperate
phages. However, as φMycoMarT7 is derived from TM4, a reportedly lytic
mycobacteriophage,65 it is possible that cellular aggregates that developed in liquid culture
provided many Mk cells in the lawn a measure of physical protection from phage infection not
afforded to the highly dispersed Ms cells.
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Figure 4: Temperature sensitive lytic growth of φMycoMarT7 on M. kansasii and M.
smegmatis lawns
(A) 10 μl of 10-fold serial dilutions of the φMycoMarT7 phage in phage buffer were spotted onto
mycobacterial lawns in top agar and incubated for 3 days (Ms) or 8 days (Mk) at 30°C or 37°C. (B) Phage
titers (pfu/ml) are presented as means and SEM calculated from at least two replicate plates incubated at
the permissive temperature (30°C).

Generation rate of transduced Kmr Mk colonies is dependent on MOI
In two small scale infection experiments utilizing the phasmid clone isolated above, we
exposed Mk to phage at multiple MOIs and obtained a total of 9,943 and 32,726 transductants,
respectively, and demonstrated for the first time that φMycoMarT7 successfully transduces this
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species. We found the frequency of transduction directly correlates with MOI (Figure 5) and
noted a rate of transduction comparable to the value (105 Kmr colonies/ml transduced culture)
previously reported for other SGM infected at a similar MOI32 (Table 2).

Table 2: Summary of φMycoMarT7 infections
Output: Kmr transductants

Total Mk
(cfu)
1.65 x
109

Total
(cfu)

0

6.86 x
109

Rate
(transductant/
input cell)

9x
1010

5.40 x
107
5.40 x
108
5.40 x
109
0

Titer
(cfu/ml)

#2

0

Infection
volume (ml)

0

Total phage
(pfu)

Mk titer
(cfu/ml)
1.49 x
109

2.40 x
108
2.10 x
108
2.40 x
108
2.40 x
108

MOI-actual

9x
1010

3.64 x
107
1.81 x
108
3.64 x
108

MOI-target

#1

Phage titer
(pfu/ml)

Trial

Input: phage + bacteria

[1:1]

[0.2:1]

0.161

5087

1:300,000

821±102

[5:1]

[0.9:1]

0.161

29300

1:59,600

4134±469

[10:1]

[1.5:1]

0.141

30900

1:56,900

4987±103

mock

[0:1]

0.161

0

na

0

[1:1]

[0.03:1]

0.240

6200

1:1,210,000

1488±305

[10:1]

[0.3:1]

0.240

22200

1:281,000

5328±1052

[100:1]

[3.3:1]

0.240

108000

1:57,200

25920±4073

mock

[0:1]

0.240

0

na

0
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Figure 5: Correlation of MOI and generation of Kmr M. kansasii colonies
Culture aliquots of Mk ATCC 12478 were washed twice, concentrated 10X, then infected in
unsupplemented 7H9 media with the φMycoMarT7 phage at a range of MOI for 4 hours at 37°C. Infection
mixtures were serially diluted, plated on 7H10 agar plates containing 30 µg/ml Km, and incubated at 37°C
for 14 days. Viable counts of Kmr colonies were calculated and compared to total cell counts of infected
Mk cultures. Error bars reflect standard error of colony counts from platings of at least two 10-fold dilutions
of infection mixtures.

We observed no Kmr colonies on any mock infection plates and report the rate of
spontaneous Km resistance from the two infections to be less than 1 in 7.44 x 106 – 3.43 x 107
exposed cells (Figure 6). Upon plating mock-exposed cultures on non-selective agar to
enumerate bacterial titer, we noted a marked discrepancy between the phage to bacterium MOI
values we targeted and the values actually obtained. This discrepancy likely arose from the
highly aggregative nature of Mk cells in culture, confounding the accurate and consistent
prediction of cfu/ml from optical density measurements and leading to an underestimation of
actual cfu present.
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Figure 6: φMycoMarT7 effectively transduces M. kansasii ATCC 12478
Aliquots of Mk cells were washed twice, then resuspended in a 0.1X volume of phage buffer, and exposed
to the φMycoMarT7 phage at an MOI of 10 or phage-free PB buffer for 4 hours. 10-fold serial dilutions of
the phage or mock infection mixtures were plated on Km or drug-free Middlebrook 7H10 agar. Counts of
Kmr colonies (reflecting individual transposon mutants) resulting from phage infection were compared to
colony counts from mock infection mixtures plated without drug and used to determine the rate of
transduction. Representative images are shown.

2.4 DISCUSSION AND CONCLUSIONS
We sought to show that the φMycoMarT7 phasmid, a mutagenic tool previously shown
to be functional in other mycobacterial species, effectively transduces and allows for the
generation of Kmr transposon mutants in Mk. As the ability of TM4-based phasmids to either
lyse or transduce in mycobacteria has been reported to be species-specific,31,63 we first
demonstrated that φMycoMarT7 does efficiently infect and lyse Mk at a rate nearly 1,000-fold
less than in Ms and creates turbid rather than clear, well-defined plaques. Although we cannot
correlate lytic potential with the rate of generation of transposon mutants as we did not
mutagenize Ms in this study, experience in our lab and that reported by others31,32 suggests that a
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correlation does not exist and mutants can be obtained even from a host the phage cannot lyse.
We recovered Kmr transposon mutants at a rate similar to that published for other slow-growing
mycobacteria, indicating that the activity of the Himar1 transposon in Mk and other species is
comparable and demonstrates the effectiveness of this mutagenesis strategy in Mk. This work
sets the stage for the use of φMycoMarT7 to generate arrayed libraries for phenotypic screening
as well as the creation of larger libraries for high-throughput sequencing studies of gene
essentiality in Mk.
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CHAPTER 3: Generation and screening of an arrayed M. kansasii transposon mutant
library

3.1 INTRODUCTION
Visual screens for abnormal colony morphology or other growth characteristics (growth
rate, auxotrophy, pigmentation) enable the rapid and concurrent assessment of high numbers of
bacterial mutants. Given the uniquely complex composition and organization of the
mycobacterial cell wall, such screens are invaluable to identify genes involved in cell wall
biosynthesis, function, and maintenance as disruptions of these processes often impact surface
characteristics of the cell such as hydrophobicity with observable effects. Many surface-exposed
cell wall components that influence colony morphology also mediate the interaction between the
bacterium and its host or the environment. As such, screens are often the first step in studies
leading to an increased understanding of mycobacterial biology and potential identification of
novel targets for therapeutics.
Although visual screening of single colonies generated at the selection step of Tn
mutagenesis would have been both rapid and efficient, the highly heterogenous nature of Mk
colonies (Figure 7) made the reliable identification of bona fide mutant phenotypes difficult. We
instead sampled individual Kmr colonies to inoculate into 96-well format culturing plates to
generate an arrayed library of transposon mutants to be stored at -80°C. Arraying mutants in this
way provided us not only a long-term, minable resource, but also the ability to generate uniform
microcultures from which we seeded multi-cfu colonies (macrocolonies) of individual
transposon mutants in an efficient, organized, and relatively high-throughput manner on several
media types. We then examined the outgrowth of these ‘spot inoculations’ for any significant
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deviation from the appearance of the consensus macrocolony appearance on each type of solid
media.

(A)

(B)

Figure 7: Alternative layouts for colony morphology screen of transposon mutants
(A) Representative 7H10 agar (Km supplemented) screening plate containing single Kmr colonies of
individual transposon mutant clones following φMycoMarT7 infection of Mk wt and Km selection; (B)
Portion of a representative macrocolony morphology screening 7H10 agar plate. Macrocolonies reflect
individual transposon mutant clones spotted from 7H9 (Km supplemented) liquid microcultures.

As the composition of the growth medium impacts the development of various features of
colony morphology, we elected to screen Mk transposon mutants on multiple media types
including standard, Congo red-containing, ‘sliding’, and nutrient restricted. The agar-based
media formulations Middlebrook 7H1066 and 7H1167 were optimized for the cultivation of
fastidious, slow-growing mycobacteria and are the current standard growth medium used today.
While both include malachite green, a diaminotriphenylmethane dye, for its antimicrobial
properties against faster growing gram-positive and gram negative organisms,68 7H11 contains a
casein digest that provides all amino acids while 7H10 is supplemented only with L-glutamate.
Commonly used in colony morphology screens,41,69,70 we included both types prepared either
with or without Congo red, a hydrophobic dye that binds lipids and lipoproteins.47 Congo red has
been used to discriminate bacterial species with variations in cell wall hydrophobicity71 and lipid
composition,72 biofilm formation capacity,50 as well as virulence.46,73 Additionally, we included
25

media with increased water content and incorporated agarose as a solidifying agent to potentially
reveal differences in sliding motility, a mechanism of flagellum independent translocation used
by mycobacteria to colonize surfaces.48,49,74 Finally, screens on media with restricted nutrient or
amino acid content have revealed auxotrophies with implications for virulence.75,76 To this end,
we included 7H10, Sauton’s,77 and M63 minimal salts78 based agars. (See Table S1 for a
complete list of media types used.)
After screening close to 800 Mk transposon library mutants on at least eight media types
each, we identified 41 mutants that consistently displayed altered or restricted growth on at least
one medium. Of the mutants we were able to confirm single transposon insertions and determine
the gene most likely impacted, we found that genes involved in either lipid metabolism or cell
wall processes were overrepresented in the pool when compared to the proportional breakdown
of genes by functional category in Mtb. Overall, the results presented here demonstrate the
feasibility of such a screen of Mk transposon mutants to identify those carrying mutations in
genes putatively leading to alterations to the cell wall.

3.2 MATERIALS AND METHODS

Plating and arraying of transposon mutants
Transposon mutants were plated on 10 cm plates containing supplemented 7H10 agar with 30
µg/ml Km (supplemented 7H10-Km) at a dilution yielding 80-100 colonies per plate and
incubated at 37°C for 14 days. Isolated colonies were picked with a sterile toothpick and used to
inoculate individual wells in a sterile 96-well tissue culture plate (Falcon, Corning) containing
200 µl supplemented 7H9 media with 30 µg/ml Km. Plates were incubated at 37°C with orbital
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shaking (170 RPM) and humidification for 7-8 days. To reduce the contribution of variable cell
densities to the appearance of mutant colonies on solid agar library screening plates, these single
colony microcultures were duplicated with a sterilized 96-pin replicator into in a new sterile, 96well plate after fully resuspending with a multichannel pipette. These sub-cultures were then
grown 7-8 days at which point culture density was measured spectrophotometrically and glycerol
in distilled water was added to a final concentration of 4%.79 Plates were sealed with adhesive
covers and stored at -80°C.

Library screening
A total of eight 96-well library plates containing saturated stock cultures of 768 Mk transposon
mutants in 4% glycerol were defrosted on ice and fully resuspended. Using an electronic
multichannel pipette with spreading tips, 5 µl of the defrosted stock was added to 195 µl
supplemented 7H9-Km in every other well of two sterile 96-well plates. These sub-cultures were
grown 8-10 days, fully resuspended, then 1.5 µl was spotted onto 245 mm square screening
plates (Corning #431111) containing various media types (Table S1) with a flame-sterilized 96pin replicator. A maximum of 288 mutants were spotted on each plate, which was allowed to dry
then sealed in a plastic bag and incubated at 37°C for 14-21 days (incubation time was dependent
on media type) until macrocolonies 0.5-1.0 cm in diameter developed. Whole plate and
individual colony images were taken with a Canon T2i digital camera and an Olympus SZX7
stereoscope, respectively, for morphological analysis.
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Collection and stock storage of unique mutants
Frozen mutant library plates were retrieved from -80°C storage and each microculture
corresponding to a screen-identified mutant was sampled with a sterile loop and subjected to two
rounds of colony isolation on 7H10 agar with 30 µg/ml Km and incubated for 14-21 days at
37°C. Single colonies were then used to inoculate 2 ml supplemented 7H9 starter cultures
containing 30 µg/ml Km and several sterile, 3 mm glass beads in sterile 14 ml culture tubes
(VWR). Tubes were incubated 6-7 days under standard conditions, but on a 35-40 degree slant to
enhance aeration and agitations. Cultures were then vigorously vortexed, allowed to settle, then 1
ml was taken from the top and used to inoculate 7 ml supplemented 7H9-Km daughter cultures
and grown as above for 4-5 days. 3 ml of these cultures were concentrated 10X in 25% glycerol
to generate frozen stocks.

Transposon detection by Southern blot
The presence of the transposon within the genomes of selected mutants was verified by Southern
blot using probe synthesis and detection kits from Roche. A 512 bp, DIG-labeled DNA
hybridization probe specific for the Km resistance cassette within the φMycoMarT7 transposon
was generated from primers GG1 and GG2 (Table S7). Genomic DNA (gDNA) from 5 ml latelog phase cultures was isolated according to standard protocol,80 quantified
spectrophotometrically (NanoDrop 2000, Thermo Scientific), and 1 µg was completely digested
with 1 U SacII (does not cut within the MycoMar transposon). 0.5 µg digested gDNA was run
alongside a DIG-labeled marker (Roche) on a 0.7% agarose gel, denatured, and transferred to a
nylon membrane (Amersham Hybond N+; GE Healthcare Life Sciences). Membranes were
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hybridized overnight following a reported protocol81 and bands were detected with NBT-BCIP
substrate after exposure to AP-linked, anti-DIG antibody.

Insertion site determination
gDNA of transposon mutants was isolated as noted above. Following the method of Siegrist and
Rubin,30 1 µg of gDNA from each mutant was fully digested with SacII and the digests were
recircularized with 1 unit T4 ligase in 100 µl reactions for 16 hours at 16°C. The ligation
reactions were ethanol precipitated and resuspended in 22 µl distilled water. 1-3 µg DNA
including the recircularized transposon-containing fragment was used to electroporate E. coli
DH5αλpir82 that were then plated on LB agar plates containing 50 µg/ml Km and incubated at
37°C for 48 hours. One transformant colony per transposon mutant was cultured overnight in LB
broth with 50 µg/ml Km and plasmid DNA (pDNA) was recovered. Plasmid samples were sent
for Sanger sequencing (Genewiz, Inc.) with the outward-facing primers CB2 and SR2b (Table
S1) which bind the oriR6K origin of replication and Km resistance gene within the transposon,
respectively. The generated sequence files were aligned to the genome of Mk ATCC 12478
(NC_022663.1) using nucleotide BLAST (BLASTn)83 (https://blast.ncbi.nlm.nih.gov/BLAST) to
determine the site of transposon insertion.

Determination of M. kansasii - M. tuberculosis gene orthology
Orthologs of the Mk genes disrupted in each screen-identified mutant were located in the Mtb
H37Rv genome (sequence ID: NC_000962.3) using the following steps: we obtained the best hit
from an initial sequence identity comparison using standard BLASTn as above; we then verified
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the presence of comparable protein features encoded by the putative orthologs; next, we
confirmed similarities in the surrounding open reading frames (ORFs) that would indicate
homologous genomic contexts (synteny); we then performed a reciprocal BLASTn search, and
confirmed the best hit returned was the initial Mk ORF identified. Orthology was verified by
performing a search of the KEGG (Kyoto Encyclopedia of Genes and Genomes) Genes database
(https://www.genome.jp/kegg/genes.html) and identifying the Mtb gene identified by BLAST
among the list of returned orthologs.
Macrocolony morphology assessment of screen-identified mutants
Cultures of Mk wt or transposon mutant strains with identified insertion sites were generated by
diluting frozen stock aliquots 1:500 in supplemented 7H9-Km and growing for 8-10 days.
Cultures were then brought to OD600 1.0 and 200 ul aliquots of the culture or fresh supplemented
7H9-Km were dispensed to wells in a sterile, 96-well culture plate (Falcon, Corning) in such a
layout as to reveal differences based on position and density effect when plated (See Results and
Figure 8). A 96-pin replicator was used to transfer approximately 1.5 µl from each well in the
plate to 8-9 15 cm plates containing different types of solid growth medium (Table S1). The
plates were incubated at 37°C and imaged at regular intervals for up to 4 weeks, depending on
media type, for morphological examination.
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(A)

(B)

(C)

Figure 8: Plate layout for multi-media assessment of macrocolony morphology
(A) Arrangement of the strain micro-cultures in a 96-well format for inoculation onto solid agar plates was
designed to assess 1) the effects of proximity to plate edge or other macrocolonies on macrocolony
morphology screening plates as well as 2) the extent of reproducibility of the strain phenotype (including
wt) on each media type. Representative plates showing Mk wt and two transposon library mutants
inoculated as in (A) and grown on supplemented 7H10 agar for 13 days (B) or M63 agarose for 27 days
(C).
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3.3 RESULTS

59 phenotypic mutants identified in screen of M. kansasii transposon library
A library of 2,760 mutants, individually arrayed across 28 96-well plates, was generated
by plating aliquots of frozen phage infection mixtures (MOI = 10:1) on supplemented 7H10-Km
agar and inoculating micro-cultures from individual colonies. A subset of 768 mutants from the
arrayed library plates were sub-cultured and replicate spotted on up to eight media types and
screened for unique phenotypes after macrocolony outgrowth. From this screen, we identified 59
mutants displaying morphologies distinct from the consensus appearance of macrocolonies on
that medium that we re-streaked for isolation and stored as frozen stocks. The overall mutant

Figure 9: Example transposon library screening plates
Image is a composite of the corresponding sections of two screening plates inoculated in an identical manner
showing macrocolonies after 19 days of growth on 7H10 agar medium supplemented with either 0.01%
Congo red (left) or 0.0085% SDS (right).
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discovery rate using this screening method was 7.7% and dependent on media type, ranging from
1.4% (M63 minimal medium solidified with agarose) to 2.9% (supplemented 7H10 agar) (Figure
10). Roughly one third of all mutant identifications (30/89) were of mutants previously identified
on a different media type. Although this relatively high value may suggest that the use of
multiple media types is not essential in this sort of screen, we felt the repeated identification of a
mutant on independent screening plates enhanced the likelihood the mutant was selected based
on a robust phenotype rather than plating artifact or subjective screener bias.
We attempted to isolate gDNA from 58 of the 59 mutants identified on the screen (one
failed to re-grow from the library plate after multiple attempts). gDNA was also taken from one
additional mutant (13B11) that did not show a unique phenotype on the screen to confirm the
presence of the transposon in a mutant not showing an altered phenotype. We performed
Southern blot analysis on gDNA from 54 of these 58 mutants and detected a single transposon in
50, strong evidence of two insertions in two, and no transposon in two (Figure S2). gDNA from
four mutants (the two lacking evidence of insertion: 14H9, 14D6; and two others that were not
analyzed by Southern blot: PB4, 15D1) failed to generate Kmr E. coli colonies in the plasmid
rescue protocol. This failure may have been due to the size or toxicity of the recircularized
transposon-containing fragment preventing either the transformation or the outgrowth of E. coli,
respectively. It is unlikely failure was attributable to the development of spontaneous Km
resistance in the mutants as we determined this rate to be exceedingly low (Figure 6). In addition
to the two mentioned above, three mutants, 16E10, 15A12, and 16E12, were not analyzed by
Southern blot.
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Figure 10: Frequency of M. kansasii mutant identification by screening media type
Up to 768 transposon mutants were screened on each media type after sub-culturing from frozen library
stock plates into supplemented 7H9-Km in sterile 96-well tissue culture plates and spotting with a 96-pin
replicator. The proportion of identified mutants among those screened on each medium is presented as a
percentage. The overall discovery rate reflects the total number of mutants identified on all media types
divided by the total number screened.

Genes related to cell wall/cell processes and lipid metabolism are enriched among screenidentified mutants
We determined the site of transposon insertion in 50 Mk mutants and found disruptions to
annotated coding regions in 43 mutants and within intergenic regions in seven. (See Table S3 for
a comprehensive analysis of the insertion sites in all 50 mutants.) Next, we plated each mutant
along with Mk wt on multiple media types at a range of spotting densities (Figure 8). We used
this strategy to generate further information about the growth and morphological characteristics
of each mutant and to identify those that we may have selected in the screen due to spotting
artifact rather than true morphological differences. For example, the transfer of large cellular
aggregates to the screening plate by the 96-pin replicator and subsequent outgrowth may have
led to the development of a colony with altered appearance from the plate consensus. We
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considered this explanation reasonable considering both the highly aggregative nature of Mk in
liquid culture and the heterogeneous nature of the replicator’s pin surfaces and shaft lengths.

Figure 11: Detail of pins on the Clonemaster™ 96-pin replicator used in this study
Image shows surface tip detail of several pins on the 96-pin inoculation device (Clonemaster™, Immusine
Labs, Inc.) used to inoculate multi-cfu macrocolonies of transposon mutants on library screening plates.
Note unequal pin lengths and grooved ends that may contribute to heterogenous delivery of mutant
microcultures.

Our results, summarized in Table S4, show that 41 of the 50 mutants again displayed
morphologies distinct to some extent from wt on at least one media type and three others
consistently appeared indistinguishable from wt on all media tested, suggesting plating artifact
was the basis for their selection. We determined cultures of six mutants had become
contaminated once we examined the re-screening plates and elected not to pursue them for
further analysis. Analysis of the transposon insertion sites in the 41 mutants showed two (13B6,
16F7) carried disruptions to genes with no clear ortholog in Mtb and three in locations where the
affected gene was unclear (13D6, 3G11, 14C5). In the remaining 36 mutants, we grouped the
genes most likely impacted by transposon insertion by the functional categorization of each’s
corresponding ortholog in Mtb H37Rv and found that, when compared to the reported
proportions of the 4078 annotated genes in Mtb based on functional assignment,84 genes related
to the “lipid metabolism” and “cell wall and cell processes” categories were notably
overrepresented (Figure 12). Although we are encouraged by these results and feel they support
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our hypothesis that a pool of mutants identified in a screen of this sort would be enriched with
those carrying alterations to the cell wall, we acknowledge the small number of genes in our
analysis and believe a larger samples size would be required to establish if this is indeed the case.

Functional category

Total

%

virulence, detoxification, adaptation

228/0

6/0

lipid metabolism

247/5

6/14

information pathways

241/2

6/6

cell wall and cell processes

773/11 19/31

stable RNAs

59/0

1/0

insertion sequences & phage

147/0

4/0

PE/PPE

168/2

4/6

intermediary metabolism and respiration

923/6 23/17

unknown

16/0

0/0

regulatory proteins

195/2

5/6

conserved hypotheticals

1081/8 27/22

Figure 12: Functional categorization of M. tuberculosis genes and genes disrupted in M.
kansasii mutants
Categorization of genes by predicted functional class in Mtb H37Rv (A) or 36 Mk transposon library
mutants (B) identified in a screen of macrocolony morphology. Total and proportional (percentage) gene
counts for Mtb as reported by Kapopoulou, et al.84 and for Mk as reported in this study are listed before and
after the slash, respectively, in the table.
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3.4 DISCUSSION AND CONCLUSIONS
In this chapter, we have demonstrated that generating and performing a macrocolony
morphology screen of an arrayed library of transposon mutants can inform gene function in Mk
and have set the stage for a much larger screen as reported in other mycobacterial species. We
identified transposon insertion sites in 50 mutants and compared by homology to orthologs in
Mtb the breakdown by functional category assignment of the genes disrupted in the 36 that we
confirmed to exhibit a morphology phenotype. The outcome of this comparison suggests that our
screen can identify mutants with transposon insertions in genes associated with lipid metabolism
or cell wall processes at a rate higher than would be expected by chance alone. However, we
recognize caveats to this assertion. First, we recognize our sample size is small enough that the
influence of chance on our results cannot be ruled out. Second, the genomes of Mk and Mtb
differ considerably in size: at 4.4 Mb, the Mtb genome is roughly 68% the size of the Mk genome
and contains 3,974 coding sequences, roughly 1,800 fewer than Mk. Finally, significant
differences between the proportional assignment by predicted function of genes have been
identified between the two organisms, with those related to signaling and gene regulation being
overrepresented and those involved in the metabolism of various compounds being
underrepresented in Mtb. In particular, 349 Mk genes are absent in Mtb, a significant number of
which are predicted to be involved in energy production and lipid and secondary metabolite
metabolism.25 Moreover, despite the genetic similarities between Mtb and Mk, the former is a
host-adapted, obligate human pathogen with no known environmental reservoir that is
considered to have descended from an ancestor of the latter, an environmental, opportunistic
pathogen.85 During this process, it is generally considered Mtb lost a significant portion of its
genomic repertoire, such as the ability to produce UV-protective carotenoid pigment or
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metabolize a variety of carbon sources, unnecessary to survival within the human niche, but
gained key virulence factors enabling successful infection and transmission, providing a rational
explanation for differences in functional assignment of genes in Mk and Mtb.
We also recognize limitations stemming from our methodology that should be addressed
to improve the outcome of future screens. First, although we attempted to inoculate screening
plates in such a way as to enable the development of roughly equivalent macrocolonies, we noted
a high level of heterogeneity in macrocolony size and topology that we do not believe reflected
truly unique morphological phenotypes. Not only did this heterogeneity obscure identification of
the baseline consensus appearance on many screening plates, it is likely the reason three of the
50 screen-identified mutants selected for insertion site identification were ‘false-positives’ and
did not display a mutant phenotype when re-plated. We feel this heterogeneity arose in part from
the particular 96-pin tool we used to inoculate the mutants onto the screening plates (Figure 11)
and in part from the characteristic ‘clumpy’ nature of Mk in liquid culture. Unequal contact
between individual pins and the agar surface due to small differences in pin length and the
grooved surface at the end of the pins led to the delivery of unequal volumes of liquid culture
and cellular aggregates to the plates, respectively. Selection of an alternative replicator with
smooth square or rounded pins of precisely the same length would likely improve inoculation
consistency, result in more homogeneous consensus macrocolonies, and reduce selection of
mutants with unrepeatable phenotypes.
Second, the extended incubation times required for full development of Mk
macrocolonies (14-28 days or longer) led to the increased occurrence of contamination following
multiple plate imaging sessions. This contamination often obscured observation and
documentation of mutant phenotypes on the screening and re-assessment plates. While some
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level of contamination is unavoidable when working with growth durations of several weeks, we
feel its impact can be minimized in a screen such as this by selecting a single timepoint for
imaging so the plate is opened only once during the extended incubation period. Additionally,
placement of the imaging station in a dead air box and out of the way of air ventilation system
openings would reduce the chances of accidental contamination with airborne fungal spores.
Finally, although feasible for a small-scale screen as we report here, we feel any increase
in the rate of detection of mutants with identifiable colony phenotypes that can potentially be
gained from the use of more than one or two media types to screen more than a few hundred
mutants is unlikely to outweigh the considerable time and expense associated with each
additional media type. When re-plated to confirm the morphology phenotypes responsible for the
selection of mutants during the screen, we found most mutants were distinguishable from wt on
standard 7H10-based agars.
Despite the methodological and experimental limitations identified above, we feel the
results we present here demonstrate the potential a modified and expanded screen would have in
a more global effort to inform gene function in Mk.
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CHAPTER 4: Characterization and complementation of two macrocolony morphology
mutants: Mk 13H8 and Mk 13D6

4.1 INTRODUCTION
To decide which of the 41 mutants identified in the macrocolony morphology screen to
pursue for further phenotypic and complementation analysis, we considered those with
disruptions to unannotated regions, genes restricted to Mk with no known function, or genes with
identifiable homologs only in other mycobacterial species to be of greatest interest. Additionally,
we considered the feasibility of successful complementation and those mutants that carried
transposons likely affecting transcription beyond a single gene were deemed less ideal. In view
of these considerations, we selected Mk 13H8 and Mk 13D6.
The gene disrupted in Mk 13H8, MKAN_RS20680, is annotated to encode a hydroxylase
widely conserved among mycobacteria, but generally listed only as a “conserved hypothetical
protein” in other species. Hydroxylases are a class of enzymes that catalyze the addition of a
hydroxyl group to a substrate, generally through the reduction of oxygen, and are involved in the
synthesis of a diversity of mycobacterial cell envelope-associated compounds from methylbranched lipids86 to peptidoglycan.87 In fact, Mk 13H8 was one of three mutants to display a
similar macrocolony morphology phenotype that had received a transposon insertion in
MKAN_RS20680, strong evidence that this gene is connected to the observed phenotype. The
wide conservation of this hydroxylase in mycobacteria in addition to its apparent relevance to
colony morphology indicated to us it may play an important cell wall-related role in Mk.
The second mutant, Mk 13D6, was of interest to us as the genomic sequence immediately
surrounding the transposon insertion site is unannotated. A closer look at the homologous region
in Mtb, though, revealed a gene encoding “B11”, a small regulatory RNA (sRNA) that was
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among those first detected in Mtb only 10 years ago by Arnvig and Young.88 Since this report,
numerous studies (focusing primarily on Mtb) have sought to draw a global picture of sRNAs
and other non-coding RNAs (ncRNAs) in mycobacteria to better understand their impact on gene
regulation.89-93 RNA-based regulators, or “riboregulators”, in mycobacteria are classified
generally into two categories: cis- and trans-acting.94 Cis-acting regulatory elements are present
on the transcript they modulate, i.e. a 5’ leader, and may be bound by trans-acting sRNAs,
regulatory proteins, or, in the case of riboswitches, ligands such as metabolites or metal cations.
Trans-acting RNAs are independent transcripts and may be encoded antisense to their targets
(asRNAs) or in distant, intergenic non-coding regions (sRNAs). Regulation by riboregulators is
often in response to an environmental cue such as a change in temperature or pH, oxidative or
anaerobic stress, or the presence of a specific metabolite or ion and the effect on the target
transcript may be activating or repressive, generally through the blocking or unblocking of
ribosome entry by hybridizing to the site of translation initiation. asRNAs extensively base-pair
to their target mRNAs, leading to downregulation either by creating dsRNA that is degraded by
RNase III or blocking ribosome entry. On the other hand, sRNAs that base-pair with their targets
generally do so imperfectly, resulting in the potential for regulating several diverse targets and
making the prediction of those targets more difficult.94-96 This particularly appears to be the case
with the B11 sRNA, which exhibits a so-called 6C motif that is widely conserved among
Actinobacteria.97 This motif is named for C-rich domains at the apices of stem-loops present in
the sRNA’s predicted secondary structure. These domains were first shown in Staphylococcus
aureus to interact with corresponding stretches of guanine bases in the Shine-Delgarno (SD)
sequences of the transcripts of several virulence genes, both blocking their translation and
promoting their RNase III-mediated degradation.98 Similarly, a recent study furthering the work
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of Arnvig and Young, who showed overexpression of Mtb B11 was lethal in Mtb and growth
inhibitory in Ms, found that the sRNA postranscriptionally repressed multiple genes when
heterologously overexpressed in Ms. Notable among them was dnaB, a gene encoding an
essential DNA helicase, whose downregulation the authors demonstrate leads to an elongated
cellular phenotype suggestive of division failure.99 Cumulatively, these studies strongly suggest
that B11 is a functional sRNA in Mk and potentially regulates several mRNA targets via C-rich
loop structures.
To better characterize the impact of the transposons in Mk 13H8 and Mk 13D6, we first
confirmed each’s unique macrocolony morphology then attempted to restore wt morphology by
complementing each with a wt copy of the disrupted gene (Mk 13H8) or gene-containing
segment (Mk 13D6). Although complementation with MKAN_RS20680, the disrupted
hydroxylase gene, along with its native promoter was sufficient to restore wt morphology to Mk
13H8, strong but only partial restoration was noted after returning an uninterrupted copy of the
intergenic region containing the B11 gene (B11-IGR) to Mk 13D6. In light of this, we extended
our complementation analysis of Mk 13D6 to explore the possibility of polar effect exerted by
the transposon on genes near B11-IGR. We found that inclusion of genes immediately adjacent
to B11-IGR did appear to fully restore the wt macrocolony morphology to the mutant. However,
real-time quantitative PCR (RT-qPCR) analysis failed to provide evidence that expression of
these genes in the mutant had been impacted. Mirroring our observations of the macrocolony
morphologies of the strains, the RT-qPCR analysis showed that complementation with B11-IGR
alone strongly but partially restored B11 expression, but inclusion of adjacent genes appeared to
confer a near wt transcript level. The basis for this enhanced restoration is unclear, but these
findings conclusively implicate B11 in Mk macrocolony morphology and suggest B11-IGR
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contains a trans-acting RNA. Overall, our results are consistent with the expected regulatory
mechanism shown for Mtb B11 and suggest that further investigation into the involvement of the
local genomic environment surrounding Mk B11 on its regulation is warranted.
As mentioned above (Section 1.6), an association between colony morphology and
virulence-associated traits of disease-causing mycobacteria is well documented.40,41,43-47,50 This
connection led us to evaluate both Mk 13H8 and Mk 13D6 in two assays relevant to virulence,
namely, the ability to form a biofilm and the ability to infect and kill the insect model host,
Galleria mellonella (Gm).
We chose to assess the biofilm formation capacity of Mk strains in light of the consistent
detection of Mk and other NTM in environmental biofilms and the suspected association of in
vivo biofilms with NTM disease (Section 1.2). Although several other methodologies to measure
accumulation of biofilm by mycobacteria have been reported (e.g. silicone tubes,100 flow cells,101
polyvinyl chloride 96-well plates,29,102 polystyrene flasks103) we chose to use the MBEC™ assay
system12 as previous work in our lab and by others have shown it to be a simple, cost-effective
and relatively high-throughput method suitable for the concurrent assessment of multiple
strains.50,104-107
As a direct measure of Mk virulence in vivo, we used the Gm larval infection model. Gm,
or the greater wax moth, is a parasite of honeybee hives with worldwide distribution whose
larvae (“waxworms”) are commonly cultivated as a food source for captive reptiles and birds.
The readily available larvae present an attractive model of microbial infection and platform for
the evaluation of antimicrobial agents that becoming increasingly common.108-110 In contrast to
other invertebrate models such as Caenorhabditis elegans and Drosophila melanogaster, Gm
larvae survive at 37°C and are large enough to handle, inject, and observe without the aid of a
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microscope or other specialized equipment. The larvae possess an innate immune response that
shares several cellular and humoral components with that of vertebrates. For example, hemocytes
circulate in the hemolymph of Gm larvae and phagocytose and kill bacterial pathogens via
mechanisms, e.g. generation of reactive oxygen species, similar to those active in mammalian
phagocytes, the intracellular niche exploited by most pathogenic mycobacteria. Gm also express
antimicrobial peptides, defensins, and melanin as part of a humoral response to microbial
infection, the latter of which provides a visible readout of larval health. Studies within the past
two years have exploited these advantages to validate the Gm model for multiple mycobacterial
species. Although M. abscessus,111 Mm, M. fortuitum,112 and M. bovis113 have been shown to be
virulent towards Gm, infection with M. aurum112 and Ms111 have minimal impact of larval
survival. To date, no studies with Mk have been reported. We present here the first use of the Gm
model in the assessment of Mk virulence and demonstrate Gm larvae are susceptible to Mk
infection.
As part of this thesis work, we report the first in vitro cultivation of Mk biofilms since the
species was first detected in biofilms inoculated from a municipal water source.100 Our findings,
which represent the first evaluation of any Mk strain using the MBEC™ system, show that
although disruption of the hydroxylase gene in Mk 13H8 did not significantly impact its capacity
to form a biofilm, the disruption to the B11 locus in Mk 13D6 resulted in an almost total biofilm
deficiency that was restored to a level insignificantly different from wt upon complementation
with B11-IGR. Thus, although it may be expected that Mk mutants selected from a screen for
altered macrocolony morphology would exhibit altered biofilm-forming ability due to the
established connection between mycobacterial cell surface properties to both phenotypes, these
phenotypes are always not associated in such mutants. Finally, our results show that transposon
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insertion did not lead to attenuation of Gm killing in either Mk 13H8 or Mk 13D6. However, we
successfully demonstrate Mk is virulent toward Gm larvae and set the stage for future use of the
model to evaluate other Mk mutants, the efficacy of therapeutics, or better understand
intracellular survival of Mk within a host.

4.2 MATERIALS AND METHODS

4.2.1. Generation of strains for complementation analysis of Mk 13D6 and Mk 13H8
mutants
Culturing conditions, molecular cloning and reagents
Mk ATCC 12478, mutant, and complemented strains were grown under standard conditions in
supplemented Middlebrook 7H9 liquid or on 7H10/7H11 agar. E. coli strains were grown
overnight at 37°C with 220 RPM orbital shaking in Luria-Bertani (LB) media. 30 or 150 µg/ml
Km was added to media when required. All DNA manipulations were carried out in either E. coli
DH5α (Invitrogen) or K12 dam-/dcm- (NEB) where appropriate. Amplification of Mk genomic
sequences for complementation were carried out according to standard PCR protocols using
DNA polymerases from New England Biolabs, Inc. (Ipswich, MA) and Takara Bio. USA Inc.
(Mountain View, CA). PCR products were cloned into the pCR™2.1-TOPO® vector using the
TOPO® TA Cloning® Kit (Invitrogen) for verification of sequence fidelity. TOPO clone
selection using 5-bromo-4-chloro-3-indolyl-β-D-galactopyranosid (X-gal, 70 μg/ml) and plasmid
DNA isolation protocols were carried out according to standard protocols using reagents
obtained from Millipore Sigma, Qiagen, and Omega Bio-Tek.
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Construction of pML1335 derived complementation constructs
A total of 10 (Mk13D6) and 2 (Mk13H8) complementation vectors were constructed from the
integrative pML1335 vector114 or its derivatives (Figure 13, Table S6). Following PCR
generation from genomic template, TOPO-cloning, sequence verification, and excision from
TOPO® vectors, inserts were combined with opened host vectors in a mass ratio of 3:1 and
ligated in 20 µl reactions at 16°C overnight with 1 U T4 DNA ligase (New England Biolabs).
Appropriate E. coli strains were transformed with 5 µl of ligation reactions, plated on LB agar
containing 150 µg/ml hygromycin (Hyg), and incubated at 37°C for 24-48 hours. Plasmid DNA
was isolated from Hyg-resistant, GFP-positive transformant colonies and candidate constructs
were restriction digested and verified by agarose gel electrophoresis.
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(A)

(B)

Figure 13: Map of pML1335 and derivation chart of vectors used in this study
(A) Map of the pML1335 integrative plasmid vector (sequence provided by Niederweis Lab, Univ. of
Alabama, School of Medicine; visualization constructed in Serial Cloner). Key genetic elements including
selection markers, regulatory elements, and restriction sites are annotated. (B) Organizational chart showing
the derivation of all complementation vectors used in the study (details of plasmid construction provided
in Table S6). Arrows point from vector backbone to derivative plasmid. Grey boxes encompass plasmids
derived from the same vector backbone .
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Transformation and strain isolation
Transformations of Mk mutant strains were carried out according to published protocols.115
Briefly, electrocompetent cells were prepared from mid-log cultures by washing four consecutive
times in decreasing volumes of room-temperature 10% glycerol. 3 µg plasmid DNA in no more
than 10 µl was incubated with 200 µl cells in 0.2 cm electroporation cuvettes at 37°C for 10 min
then pulsed in a Gene Pulser electroporator (BioRad) set to 2500 V, 1000 Ω, 25µF. Pulsed cells
were resuspended in 5 ml pre-warmed 7H9 media and incubated overnight at 37°C with shaking
at 170 RPM, then concentrated 10-fold, and plated on supplemented 7H10 Km/Hyg agar plates.
Transformant colonies were examined after incubation at 37°C for 14-21 days and cultures of
GFP+ colonies were generated after re-streaking twice for isolated colonies on supplemented
7H10 agar with appropriate antibiotics to ensure stock purity. In total, we constructed 12 strains
as listed in Table S5.

4.2.2. Phenotypic analysis of Mk13D6 and Mk13H8 mutants and complemented strains

Bacterial strains and growth conditions
Cultures used in all phenotypic assays were prepared similarly. Concentrated frozen stocks
(~OD600 10) were inoculated 1:100 into 2 ml supplemented 7H9 with appropriate antibiotic in 14
ml culture tubes (VWR). These starter cultures were incubated on a 50 degree slant with 5-10
sterile, 3 mm glass beads under standard conditions for 3-4 days or until visual turbidity. OD600
was determined from an aliquot of starter culture following a 30 sec disruption of aggregates in a
Disruptor Genie (Scientific Ind.). 5 ml daughter cultures were inoculated from starter cultures to
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an OD600 0.01-0.05 in 50 ml sterile culture tubes (Falcon, Corning) and incubated as before to
mid-log (OD600 0.4-0.7).
Examination of macrocolony/single colony morphology
To evaluate complementation of mutant strains, all strains were cultured as outlined in preceding
paragraph, brought to an OD600 of 1 with fresh 7H9 medium, then arrayed in 200 µl aliquots to a
sterile 96-well tissue culture plate. Using a flame-sterilized 96-pin replicator, 1.5 µl drops were
deposited on pre-dried 15 cm supplemented 7H10 agar plates and allowed to dry, lid open, in a
BSC. To prepare plates for single colony isolation, a sterile loop was used to streak a sample of
the above prepared cell suspensions onto 10 cm plates of the same medium. All plates were then
closed, sealed with plastic wrap, placed into sealable bags, and incubated at 37°C in the dark for
2-4 weeks. Macrocolony and single colony images were acquired as in Section 3.2 with a Canon
DSLR camera and an Olympus stereoscope.
RNA isolation
Cultures grown to early- to mid-log phase were immediately moved to ice and aliquots
containing 1-3 x 107 cfu were pelleted and processed for RNA isolation. All centrifugation steps
were performed at 4°C. Pellets were resuspended in 1 ml TRIzol reagent (Invitrogen) and
disrupted with zirconia/silica beads in a bead-beater (Mini-BeadBeater 16, BioSpec Products,
Bartlesville, OK; USA) for two successive 50 sec cycles, each followed by 10 min on ice. The
sample was then spun at 22,000 x g for 2 min to pellet the beads and cellular debris. The
supernatant was moved to a new siliconized microcentrifuge tube, combined with 300 µl
chloroform:isoamyl alcohol (24:1), shaken vigorously for 15 sec, and incubated at 25°C for 3
min. Following centrifugation (12,000 x g for 15 min), 95% ethanol was added to the supernatant
to a final concentration of 35%, and the sample was further processed using Purelink™ micro and
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total RNA isolation kits (ThermoFisher Scientific) according to manufacturer’s protocol. RNA
was eluted in RNase-free water, quantified spectrophotometrically (NanoDrop™ 2000;
ThermoFisher Sci.), and stored at -80°C.
Real-time quantitative PCR
One-step RT-qPCR experiments were performed using QuantiNova® SYBR® Green RT-PCR kit
reagents and target-specific primers (Table S7). Optimized RT-qPCR primers were found to
have efficiencies greater than 90% (based on standard curves generated from 10-fold serial
dilutions of Mk wt gDNA) and produce unique amplicons (as judged by melt curve analysis) of
the expected size (as judged by agarose gel electrophoresis). Equal masses of total and micro
RNA from each sample were combined and treated with TURBO™ DNase (Ambion) to remove
gDNA contamination. Reactions (10 µl) containing 30 pg template RNA were run in a RotorGene Q light cycler (Qiagen) under recommended conditions. Cycling was performed as
follows: 95°C for 5 sec and 60°C for 10 sec for 40 cycles. For each transcript target, the
threshold cycle (Ct) was normalized to the Ct of the standard mycobacterial internal calibrator
sigA transcript to generate transcript relative abundance data as reported.116,117
MBEC™ biofilm plate assay
Inoculation and staining of biofilms grown using MBEC™ assay plates was performed similarly
reported protocols.50,107 Log phase (OD600 0.5-0.7) cultures were pelleted, resuspended in 7H9
media lacking ADN supplementation, Tween-80, and antibiotics to OD600 0.1, and inoculated
(150 µl/well) into MBEC™ P&G biofilm assay plates (Innovatech). Plates were sealed with
Scotch™ tape, placed in a sealable bag, and secured in a locking plastic container to reduce
media evaporation. The container was placed at 37°C in a humidified incubator and rotated at
100 RPM for six weeks. Biofilm-coated pegs were washed twice with distilled water, dried at
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room temperature for two hours, stained for 15 min with 0.5% crystal violet, and dried overnight.
The next day, peg lids were immersed in 95% ethanol for two hours to extract the crystal violet
and Abs595nm was measured.
G. mellonella larvae infection assay
Inoculum preparation Daughter cultures of Mk strains were generated by inoculating 25 ml
supplemented 7H9 lacking antibiotic in a sterile Erlenmeyer flask with 3 mm glass beads and
sufficient volume of a starter culture to achieve an estimated OD600 of 0.05. Cultures were grown
for 2-3 days to early-mid log phase (OD600 = 0.4-0.5), then pelleted at 4,700 x g for 10 min at
25°C, and resuspended with phosphate buffered saline (PBS, as reported elsewhere118) to roughly
twice the target optical density. Aliquots of resuspended cells were divided equally among 1.7 ml
microcentrifuge tubes containing 7-10 3 mm glass beads and subjected to a 30 sec disruption
cycle (Disruptor Genie, Scientific Ind.) to break up cellular aggregates. Aliquots were then
recombined in a sterile 15 ml tube and left undisturbed for 3 min at 25°C to allow any remaining
aggregates to settle out. The supernatant was moved to a new sterile culture tube and the optical
density was adjusted as needed with PBS to attain a density of 1.0 x 108 cfu/ml. Inoculum
density was verified by plating serial dilutions on supplemented 7H11 agar plates containing 150
µg/ml Hyg and incubating for 10-14 days at 37°C.
Infection of G. mellonella larvae Sixth (final) instar113 larvae were purchased from Timberline
Industries (Marion, IL) and experiments were performed on the day of delivery. All larvae were
inspected for healthy movement and any signs of melanization and only those weighing 150-250
mg were used in experiments. Groups of 15 larvae were moved using blunt-tipped forceps into
paper-lined 10 cm glass petri dishes and individual larva were restrained for injection using
published technique.119 10 µl of either 1 x 107 cfu or PBS alone were injected into the last left
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pro-leg using a 22s ga beveled stainless steel needle affixed to 50 µl Hamilton syringe presterilized by flushing three times with 95% ethanol and once with sterile distilled water. One set
of larvae per experiment (non-injected control) were handled with forceps but not injected.
Dishes containing all larvae were placed in a foil-covered box in an incubator at 37°C or 25°C
and observed every 24 hours for survival. Immune response to pathogen invasion is marked by
the deposition of polymerized melanin intended to encapsulate the infection, similar to abscess
formation, visible initially as a brown spot at site of injury site and, gradually, as a total
darkening of the body as the infection proceeds and the larva dies. Larvae that did not move in
response to touch were considered dead. Kaplan-Meier curves were used to plot survival and
comparisons were performed using the logrank test (Prism 6, GraphPad Software, Inc.).

4.3 RESULTS

Characterization of Mk 13H8 and complementation of (macro)colony morphology
The Mk 13H8 mutant displayed a smoothed, lobular morphology compared to the more
roughly textured consensus appearance of macrocolonies on supplemented 7H10 agar screening
plates (Figure 15). We determined the transposon in Mk 13H8 lay 70.1% of the entire ORF
length away from the 3’ end of MKAN_RS20680. Two additional mutants (PF6, 15D4) carried
disruptions to the same gene and grew into macrocolonies similar in appearance to Mk 13H8.
However, as the disruption in Mk 13H8 was the most distal (nearest the 5’ end) of the three, we
felt it was the most likely to have abrogated expression of MKAN_RS20680 and the least likely
of the three mutants to produce a truncated protein. Additionally, while MKAN_RS20680 is
encoded on the negative strand, both adjacent genes are non-overlapping and encoded on the
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opposite strand, reducing the likelihood of transposon-mediated polar effect. For these reasons,
we felt Mk 13H8 was an interesting mutant and offered an increased chance of successful, singlegene complementation.
To complement Mk 13H8, we first cloned the MKAN_RS20680 ORF into plasmids
derived from pML1335, an integrative vector encoding two selection markers: hygromycin
phosphotransferase (hyg) and a variant of GFP (gfpm2+) with increased fluorescence that is codon
optimized for expression in mycobacteria (Figure 13).114 (See Section 4.2.1. and Table S6 for
details of plasmid construction.) To increase our chances of successful complementation, we
constructed two vectors: pML-WCB4h carries the hydroxylase under its putative native promoter
and in pML-WCB2h, the hydroxylase was placed under the control of the high expression
promoter, MOP120 (‘mycobacterial optimized promoter’).
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(A)

(B)

(C)
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Figure 14: Comparison of the MKAN_RS20680/Rv3210c locus in Mk 13H8 and M.
tuberculosis
(A) MKAN_RS20680 (696 bp) was placed under either MOP or its own putative promoter in plasmids
pML1335-WCB2h and pML1335-WCB4h, respectively, and transformed into the Mk 13H8 mutant. Names
of complemented strains and coordinates of Mk genomic sequence included in complementation vectors
are shown. Nucleotide (nt ID) and amino acid (aa ID) identity between the indicated Mk and Mtb orthologs
are shown and expressed as percentages. (B) Sequence alignment between the MKAN_RS20680/Rv3210c
loci in Mk (sequence ID: NC_022663.1; nt 4736029-4736228 shown) and Mtb (sequence ID:
NC_000962.3; nt 3587639-3587440 shown). Gray shading corresponds to 100 bp of the 5’ ORF end. Black
bar denotes 92 bp sequence included upstream of MKAN_RS20680 ORF in pML1335-WCB4h. (C) Image
is a screenshot from the user interface of the Interactive Genomics home page of the Wadsworth Center
(NYS Dept. of Health): https://mtb.wadsworth.org. Shown is a window of transcriptomic data obtained
from an exponential culture of Mtb centered on the Mtb genomic region orthologous to the Mk genomic
region shown in (A). The histograms reflect total RNA reads that map to the negative (red) or positive
(blue) strands of the Mtb genome (sequence ID: NC_000962.3). Genomic coordinates and ORF ID’s are
indicated above the RNA read data. Note: all Mk and Mtb gene orientations are shown as currently annotated
in the NCBI database.

Our inclusion of the 92 bp upstream of MKAN_RS20680 was informed by two key pieces
of information. First, an alignment between MKAN_RS20680 and Rv3210c from Mtb shows
83.2% sequence identity across 98% of the genes’ lengths, suggesting Rv3210c is a true
ortholog. Matching orientation and a high level of similarity is also seen between the genes
adjacent to the putative orthologs (Figure 14A). Second, data from a recent study reporting
comprehensive transcriptomic data from logarithmic Mtb cultures121 indicates Rv3210c is
expressed as a leaderless transcript lacking a 5’ UTR (untranslated region) and SD sequence
(Figure 14C). This evidence suggests the promoter sequence abuts the dual
transcriptional/translational start site of Rv3210c. An alignment between the intergenic regions
upstream of the Mk and Mtb orthologs indeed revealed increased sequence conservation in the
100 bp directly upstream of the putative transcriptional start site of both genes. (Figure 14B) We
felt this region likely included the native promoter sequence.
Transformation of the Mk 13H8 mutant with plasmids pML-WCB4h and pML-WCB2h
yielded Mk 13H8-HXnative and Mk 13H8-HXhigh, respectively. Successful plasmid integration was
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confirmed by selection of GFP positive and Hyg-resistant transformant colonies. After
generating a frozen stock, we plated both complemented strains on supplemented 7H10 agar for
macrocolony and single colony analysis. We observed a significant if not complete restoration of
the wt macrocolony morphology to the mutant regardless of complementing vector (Figure 15AB). This restoration was mirrored in the topology of the heaviest streak on the single colony
isolation plates (Figure 15). Interestingly, although we observed a reduced single colony
diameter in Mk 13H8 and the two other mutants with disruptions to MKAN_RS20680, it later
appeared to be a developmental delay that is gradually overcome in time. The size of 14-day-old
Mk 13H8 colonies appear smaller than those of wt, but both are similar in size by day 27. 14day-old colonies of both Mk13H8-HXnative and Mk13H8-HXhigh strains do not appear to exhibit
this growth delay, again suggesting complementation (Figure 16). In addition, although we
regularly observed small deposits of red pigment on yellow pigmented colonies of wt Mk that
had received a significant duration (1-3 hrs) of exposure to fluorescent lighting followed by 2-3
days of growth at 37°C, these deposits were absent in the mutant. This red pigment is likely
lycopene, an intermediate in the carotenoid biosynthetic pathway, conserved among
chromogenic mycobacteria. The primary end product of this pathway, beta-carotene, lends a
yellow color to Mk colonies following exposure to light.122 The visible accumulation of lycopene
on the surface of wt, but not mutant, colonies may indicate a difference in cell surface
hydrophobicity between the strains. This difference, potentially the result of unique lipid
compositions, may lead to aggregation (“beading up”) of lycopene molecules on the surface of
the wt colony, but dispersal within the mutant colony. Finally, close examination of the colony
edge of the mutant revealed a semi-translucent border, wider and smoother than that typically
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seen on wt colonies. Both characteristics of single Mk 13H8 colonies were restored in the
complemented strains (Figure 17).
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Mk WT-v

Mk 13H8-v

Mk 13H8-HXnative

Mk 13H8-HXhigh

Figure 15: Mk 13H8 complementation: macrocolony morphology
OD600 1.0 cultures (1.5 µl) were spotted (A, B) or streaked (C, D) on supplemented 7H10 agar and grown at 37°C for 20-23 days. Bars represent 2
mm (A, B), 5 mm (C), or 0.5 mm (D). Images in (B) and (D) are magnifications of boxed regions in (A) and (C), respectively. All images are
representative of the strains indicated.
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Mk WT-v

Mk 13H8-v

Mk 13H8-HXnative

Mk 13H8-HXhigh

Figure 16: Mk 13H8 complementation: single colony growth
Concentrated frozen stocks of the indicated strains were streaked for isolation on supplemented 7H10 agar, grown at 37°C for 14 days in the dark,
and plates were imaged (top row). The same plates were reincubated a total of 13 days. During this time, the plates were imaged again (day 20),
exposed to direct fluorescent light for 2 hours (day 24), and re-imaged (day 27, bottom row). Images are representative.
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Mk WT-v

Mk 13H8-v

Mk 13H8-HXnative

Mk 13H8-HXhigh

Figure 17: Mk 13H8 complementation: single colony morphology
Images are representative of 27-day-old colonies from plates seen in Figure 16, bottom row. Images in middle and bottom rows are magnifications
of boxed areas in top row images. Scale bars are 0.5 mm.

Biofilm formation and virulence toward G. mellonella are unaffected by transposon in Mk
13H8 mutant
Considering that altered cell surface properties may have led to the macrocolony
morphology of Mk 13H8, we evaluated the ability of the mutant to form a biofilm, a phenotype
strongly impacted by these properties. We found that although the Mk 13H8 mutant formed on
average roughly 30% less biofilm than wt on the surface of the polystyrene pegs of the MBEC™
biofilm assay plates, the difference between the strains was not statistically significant. Similarly,
the 31% and 52% increases in biofilm accumulation observed for the Mk 13H8-hnative and Mk
13H8-hhigh strains, respectively, suggests trends of slightly increased capacity over wt, but the
difference was not significant (Figure 18).

Mk WT-v

Mk 13H8-v

Mk13H8-HXnative

Mk13H8-HXhigh

Figure 18: Mk 13H8 phenotypic assessment: biofilm production
Microcultures of the indicated Mk strains were incubated for six weeks in MBEC™ biofilm assay plates.
Absorbances at 600 nm (A600) of 95% ethanol after a two hour extraction of crystal violet stained assay
plate pegs are expressed as a percentage of the wt value and reflect accumulated biofilm biomass. Mean
and standard error two independent replicates is presented. The mean A600 value from uninoculated wells
was subtracted from all data prior to analysis. Images show representative pegs following crystal violet
extraction and reflect the strain for which data is presented directly below; media, uninoculated well;
analysis using student’s t-test found no significant differences.
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To assess any impact on virulence of the transposon insertion in Mk 13H8, we injected
107 cfu of Mk wt and the Mk 13H8 mutant into Gm larvae. We found no statistically different
level of killing between the strains: both killed roughly 50% of the larvae by day 17 of the 3week observation period. A representative plot of two independent experiments in shown in
Figure 19.

Figure 19: Mk 13H8 phenotypic assessment: G. mellonella killing
Groups of 16 larvae were injected with 1 x 107 cfu wt (WT), 13H8 mutant (13H8) Mk strains or phosphatebuffered saline vehicle (PBS) (10 µl/larva). (NIC; non-injected control). All groups were incubated at 37°C
in the dark and monitored daily for survival. Data shown are representative of two independent experiments.
Statistical differences between survival curves were calculated using the Log-rank test. p values; *, < 0.05;
ns, difference is not significant.

Characterization of Mk 13D6 and partial complementation of (macro)colony morphology
with B11-IGR alone
The reduced size and highly mucoid surface topology of the Mk 13D6 macrocolony was
one of the most unique phenotypes observed in the screen. Macrocolonies of the mutant
consistently showed this strong phenotype (Figure 23), that also characterized isolated, single
colonies (Figure 24). As the transposon in Mk 13D6 fell within a ~500 bp intergenic span 343 bp
upstream of MKAN_RS12130 on the negative strand and 161 bp upstream of MKAN_RS12135
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on the positive strand, it seemed reasonable that the regulatory elements of either or both genes
may have been disrupted. Interestingly, alignment of the entire Mk genomic fragment
encompassing the intergenic region and two adjacent genes to the genome of Mtb revealed a
homologous context that included orthologs of MKAN_RS12130 (Rv3660c) and
MKAN_RS12135 (Rv3661) as well as the 93 bp, sRNA-encoding B11 gene on the negative
strand. Comparison of the two intergenic regions revealed a high level of sequence identity only
at the position of the sRNA, good evidence that it is conserved in Mk and its disruption may
influence the phenotype of Mk 13D6 (Figure 21A). Indeed, when we folded the RNA sequence
derived from the genomic coordinates in Mk homologous to Mtb B11 using mFold (mFold Web
Server: http://unafold.rna.albany.edu/?q=mfold), we noted a secondary structure nearly identical
to that predicted for Mtb B11 by the study first reporting its detection.88 (Figure 20B). The same
study also noted the presence of the consensus promoter sequence recognized by the
transcription factor, sigA, immediately upstream of the sRNA coding sequence. Upon closer
examination, we found the extent of the sequence conserved between Mtb and Mk included this
predicted promoter and that it had been separated from the sRNA (herein referred to as Mk B11)
by the transposon in Mk 13D6 (Figure 20A). This led us to hypothesize that the mutant’s
strongly mucoid morphology resulted from the eliminated or strongly reduced expression of Mk
B11, which we later confirmed with RT-qPCR analysis (Figure 25A-B).

63

(A)

(B)

Figure 20: The ‘B11’ sRNA in M. kansasii and M. tuberculosis
(A) Sequence alignment of the B11-encoding locus from Mk (Sequence ID: NC_022663.1; nt 28102422810102 shown) and Mtb (Sequence ID: NC_000962.3; nt 4099515-4099376 shown). The location of the
transposon (inverted triangle) and putative promoter and terminator sequences are indicated. The sRNA
sequence is shaded grey. Asterisks indicate nucleotide identity. (B) sRNA structural predictions and folding
minimum free energies were generated with the mFold web server123 using default parameters.

The presence of Mk B11, the gene encoding the putative homolog of the Mtb B11 sRNA,
immediately adjacent to the transposon insertion site in Mk 13D6 led us to focus our initial
complementation efforts on the intergenic span containing the sRNA. Based on our hypothesis
that transcription of the sRNA was blocked by the inserted transposon, we constructed four
vectors from the integrative pML1335 plasmid114 with the goal of driving Mk B11 expression to
a native or higher-than-native level to restore wt morphology to the mutant. To this end, we
cloned into the vectors the 250 bp between the presumptive 3’ end of Mk B11 and the annotated
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5’ end of MKAN_RS12130 in addition to one of the following: 1) Mk B11 placed under the weak
mycobacterial promoter, pwmyc; 2) Mk B11 placed under the strong mycobacterial promoter,
MOP; 3) Mk B11 along with 31 bp of upstream sequence containing the putative sigA-dependent
promoter, or; 4) Mk B11 and the entire 161 bp intergenic region up to the annotated 5’ end of
MKAN_RS12135. (See Table S6 for a detailed description of all vectors.) After transformation
of Mk 13D6 with each of the four vectors, we found that only the fourth complemented strain
(“Mk 13D6-R”) carrying an integrated, uninterrupted copy of the entire intergenic, Mk B11containing span (herein referred to as ‘Mk B11-IGR’) showed partial restoration of wt
macrocolony appearance (Figure 23), while the other three appeared identical to the mutant
(data not shown).
Our observation of the significant, but only partial complementation of the macrocolony
phenotype in Mk 13D6-R, convinced us disruption of Mk B11 transcription was very likely
involved in the mutant phenotype. However, we expanded our complementation efforts to test
the possibility that in addition to a putative impact on Mk B11 expression, the transposon exerted
a polar effect on one or both adjacent genes that contributed to the morphology of Mk 13D6. The
distance between the transposon and the two genes abutting the intergenic region (343 bp
downstream and 161 bp upstream of Mk B11 on the negative and positive strands, respectively)
and their orientation led us to consider both for inclusion in additional complementation vectors.
Further, inspection of the Mtb and Mk genome sequences showed that the high nucleotide
similarity between B11 and its putative promoter in the two species extended to and beyond the
two adjacent genes and revealed that MKAN_RS12130 and Rv3660c are homologous to the tadZ
gene of the tad (‘tight adherence’) locus, an operon encoding a type IV pilus assembly system.
The tad locus was initially identified in Aggregatibacter actinomycetemcomitans, a gram-

65

negative human pathogen, and later found to consist of a total of 14 genes.124-126 However,
although the locus is widely conserved among prokaryotes, many tad genes are absent from
actinobacterial species, including mycobacteria.127 The highly homologous tad loci in Mk and
Mtb both contain homologs of only 7 tad locus genes: TadZ, TadA, TadB, TadC, flp1, TadE, and
TadF. (Although the paralogous pseudopilins TadE and TadF are present, they are not
considered true tad system proteins as they lack the N-terminal motifs conserved in other
bacterial taxa that are thought to be processing sites for proteolytic cleavage and thus are likely
non-functional.127,128) An examination in Mtb found that multiple genes of the tad operon are
expressed as a single transcript.129 This pattern of co-transcription is supported by more recent
RNAseq data that suggests the operon is transcribed in two parts: Rv3660c-Rv3659c and
Rv3658c-Rv3654c. Additionally, the transcripts of both Rv3660c and Rv3661 appear to have 5’
UTRs, each having a transcriptional start site somewhere within or near the 5’ end of Mtb B11.121
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Figure 21: Comparison of the B11 loci in M. kansasii and M. tuberculosis
(A) Direct nucleotide sequence comparisons between orthologues (indicated by corresponding colors) in
Mk ATCC 12478 (Mk, sequence ID: NC_022663.1) and Mtb H37Rv (Mtb, sequence ID: NC_000962.3)
were made using BLASTn. Direct amino acid sequence comparisons between protein products of indicated
ORFs were made using BLASTp. Direct nucleotide sequence comparisons between indicated intergenic
regions (IGR) were made with Serial Cloner. Light grey arrows represent bordering ORFs not included in
analysis. Arrows representing ORFs, spaces representing intergenic regions, and extents of ORF overlap
are drawn to scale. (B) Image is a screenshot from the user interface of the Interactive Genomics home page
of the Wadsworth Center (NYS Dept. of Health): https://mtb.wadsworth.org. Shown is a window of
transcriptomic data obtained from an exponential culture of Mtb centered on the genomic region depicted
in (A). The histograms reflect total RNA reads that map to the negative (red) or positive (blue) strands of
the Mtb genome (sequence ID: NC_000962.3). Genomic coordinates and ORF ID’s are indicated above the
RNA read data.

Considering this transcriptional data and the high level of nucleotide sequence homology
between Mk and Mtb in the region of B11, we elected to include genomic sequence containing
genes surrounding Mk B11 in six further complementation vectors. Figure 22 shows the regions
included in each of these vectors. As the 503 bp intergenic region containing Mk B11
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complemented Mk 13D6 to a significant extent, we included it in four of the six vectors in
addition to one or multiple adjacent genes in the event an additive effect would lead to full
complementation. We included only MKAN_RS12135, encoding an uncharacterized hydrolase,
in the final two vectors, to test the hypothesis that disruption to its expression contributed to the
macrocolony phenotype of Mk 13D6 in a significant way. MKAN_RS12135 was cloned alone,
either under the control of either a putative native promoter or MOP, in the two vectors as it does
not appear to be part of an operon.

Figure 22: Genomic sequence included in Mk 13D6 complementation plasmids
The 94 bp gene encoding the Mk homolog (ncMKAN_RS112130Ac, or “Mk B11”) of the Mtb B11 gene
(ncRv13660c) was placed with 244 bp downstream intergenic sequence under pwmyc130 ( pML1335-WCB1),
MOP120 (pML-WCB2), 37 bp sequence upstream of the sRNA containing its putative promoter88
(pML1335-WCB3), or the entire 176 bp upstream intergenic sequence (pML1335-WCB4). Mk B11-IGR
(503 bp) was included with either MKAN_RS12135 alone (pML1335-WCB4.1), MKAN_RS12125MKAN_RS12130 (pML1335-WCB4.2), MKAN_RS12100-MKAN_RS12130 (pML1335-WCB4.3), or
MKAN_RS12100-MKAN_RS12135 (pML1335-WCB4.4). Two additional constructs included only
MKAN_RS12135 placed under either MOP (pML1335-WCB2.1) or 194 bp of upstream genomic sequence
containing its putative promoter (pML1335-WCB2.2). Names of complemented Mk 13D6 strains and
coordinates within the Mk genome (sequence ID: NC_026633.1) of sequence included in complementation
vectors are included where appropriate.
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Full complementation of (macro)colony morphology of the Mk 13D6 mutant
We observed full restoration of the wt macrocolony morphology to those mutant strains
that received Mk B11-IGR in addition to at least the first two genes of the tad locus or
MKAN_RS12135 (Mk 13D6-RAZ, Mk 13D6-Rtad, Mk 13D6-RtadH, Mk 13D6-RH). Those
strains that did not receive Mk B11-IGR (Mk 13D6-Hhigh, Mk 13D6-Hnative) showed no
morphological complementation and macrocolonies appeared as those of the mutant (Figure 23).
We observed a similar pattern of complementation of single colony morphology for all strains
(Figure 24).
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Mk WT-v

Mk 13D6-v*

Mk 13D6-R

Mk 13D6-RHΔ

Figure 23: Mk 13D6 complementation: macrocolony morphology
OD600 1.0 cultures (1.5 µl) were spotted (A) or streaked (B, C) on supplemented 7H10 agar and grown at 37°C 20-23 days. Bars represent 2 mm (A,
C) 1 cm (B). Images in (C) are magnifications of boxed regions in (B). All images are representative of the strains indicated. (*Appearance also
typical of Mk 13D6-Hnative and Mk 13D6-Hhigh; Δ Appearance also typical of Mk 13D6-RAZ, Mk 13D6-Rtad, and Mk 13D6-RtadH)
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Mk WT-v

Mk 13D6-v*

Mk 13D6-R

Mk 13D6-RHΔ

Figure 24: Mk 13D6 complementation: single colony morphology
Concentrated frozen stocks of the indicated strains were streaked for isolation on supplemented 7H10 agar grown at 37°C for a total of 27 days.
During this time, the plates were kept in the dark except when imaged (day 14 and 20), exposed to direct fluorescent light for 2 hours (day 24), and
then re-imaged on day 27. Single colonies from isolation streak plates (A) are shown in (B). Enlargements in (C) are of boxed regions in (B). Images
are representative for the indicated strains. Bars represent 1 cm (A) or 1 mm (B, C). (*Appearance also typical of Mk 13D6-Hnative and Mk 13D6Hhigh; ΔAppearance also typical of Mk 13D6-RAZ, Mk 13D6-Rtad, and Mk 13D6-RtadH)

Transposon disrupts transcription of Mk B11 in Mk 13D6 mutant
We investigated the possibility that the transposon insertion in the Mk 13D6 mutant six
base pairs from the sequence encoding Mk B11 separated it from its putative promoter and
negatively impacted expression of the sRNA. Using RT-qPCR analysis, we detected severely
(807-fold) reduced transcription of Mk B11 in total RNA isolated from log-phase cultures of Mk
13D6 (Figure 25A, B). Although the reduction was quite strong, we believe expression was not
fully eliminated in the mutant due to the promoter of the Km cassette in the transposon, which
has been shown to drive expression of genes adjacent to the transposon-genome junction in other
studies.27,131 Complementation with the intergenic region alone (Mk 13D6-R strain) greatly
restored Mk B11 expression to within two-fold of the wt. However, we noted full restoration in
the Mk 13D6-RH strain where Mk B11 expression was not significantly different from wt.
Perhaps not unexpectedly, Mk B11 levels in the Mk 13D6-H strain were nearly the same as in the
mutant confirming the necessity of Mk B11-IGR in restoring Mk B11 expression in the mutant.
Interestingly, our results show the transposon in Mk 13D6 did not impact transcript levels
of either adjacent gene suggesting that, at least at the level of transcription, the mutant phenotype
is most likely the direct result of disruption to endogenous expression of Mk B11 (Figure 25CF). Of note, we found strong evidence of increased transcript levels of MKAN_RS12135 in
strains complemented with a second copy of this gene. Despite this, the fact that the
macrocolony appearances of the Mk 13D6-RH and Mk 13D6-H strains matched that of the wt
and the Mk 13D6 mutant, respectively, suggests little to no contribution of MKAN_RS12135
dysregulation to macrocolony morphology in Mk (Figure 23).
Finally, as the phenotype of the Mk 13D6 mutant was most pronounced when grown as a
multi-cfu seeded colony on solid agar medium, we postulated the expression of Mk B11 or the
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adjacent genes in cells within these colonies may differ from those in liquid culture and
potentially inform the basis of the observed mutant phenotype. To this end, we isolated total
RNA from samples of equal biomass taken from 23-day-old colonies of each strain for use in
RT-qPCR experiments parallel to those discussed above. We found similar expression patterns
of all strains for all genes analyzed. This suggests that neither the near-elimination of Mk B11
expression nor endogenous levels of the immediately adjacent genes in the Mk 13D6 mutant
strictly depend on cellular growth phase or physiologic state.
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Figure 25: RT-qPCR expression analysis of Mk B11 and adjacent genes
Total RNA isolated from pelleted aliquots of mid-log phase (OD600 = 0.5-0.7) cultures (A, C, E) or 23-dayold macrocolonies grown on 7H10 agar (B, D, F) was used as template for RT-qPCR experiments.
Expression levels of B11 (A, B), MKAN_12135 (C, D), and MKAN_12130 (E, F) relative to sigA are
presented as percent of wt. Data represent the means and SEM of at least two independent experiments.
Mk WT-v; Mk 13D6-v; Mk 13D6-R; Mk 13D6-RH; Mk 13D6-Hnative. Student’s t-test p values
versus wt: *, <0.05; **, <0.01; ns: no significant difference.
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Biofilm deficiency in Mk 13D6 fully restored in complemented strains; mutant is not
attenuated in G. mellonella infection model
As noted previously, the connection between cell surface properties, (macro)colony
morphology, and the ability to form a biofilm is well documented for mycobacteria.40,48,50,132
This led us to investigate the biofilm forming capacity of the Mk 13D6 mutant using the MBEC™
assay system. We found that while Mk wt was able to form significant biofilm over the 6-week
growth period, the mutant did not form any detectable biofilm (). We also observed
complementation in the Mk 13D6-R strain was on average 63% of, but not significantly different
from, wt. This lack of significance likely arises from the high level of variability typical of this
assay. The Mk 13D6-RH strain formed biofilm at 158% the rate of wt, while the Mk 13D6-H
complement did not form appreciable biofilm. To our knowledge, this is the first time biofilm
formation by any Mk strain has been quantitatively evaluated.
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Figure 26: Mk 13D6 complementation: biofilm formation
Microcultures of the indicated Mk strains were incubated for 6 weeks in MBEC™ biofilm assay plates.
Absorbance at 600 nm of 95% ethanol after a two-hour extraction of crystal violet stained assay plate pegs
is expressed as a percentage of the wt value and reflects accumulated biofilm biomass. Mean and standard
error of ≥ two independent replicates is presented. Images show representative pegs following crystal violet
extraction and reflect the strain for which data is presented directly below. The mean A600 value from
uninoculated wells was subtracted from all data prior to analysis. WT, Mk WT-v, M, Mk 13D6-v; R, Mk
13D6-R; RH, Mk 13D6-RH; RAZ, Mk 13D6-RAZ; H, Mk 13D6-Hnative; media, uninoculated well. student’s
t-test p values < 0.05 versus wt (*) or M (Δ)

In the first use of the Gm infection model to assess the virulence of Mk, we injected 1 x
107 cfu of Mk wt into Gm larvae and noted a significant decrease in survival following injection
culminating in complete larvae death after 14 days. To evaluate any potential impact on
virulence of the transposon in Mk 13D6, we injected an equivalent dose of the mutant, but noted
no change in survival rate of the larvae (Figure 27A). Interestingly, as has been noted in other
studies,133,134 decreasing the post-injection maintenance temperature of the larvae to 25°C from
37°C conferred near total protection from killing by both Mk wt or Mk 13D6 (Figure 27B).
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Figure 27: Mk 13D6 phenotypic assessment: G. mellonella killing
Groups of 16 larvae were injected with 1 x 107 cfu wt (WT), 13D6 mutant (13D6) Mk strains or phosphatebuffered saline vehicle (PBS) (10 µl/larva). (NIC; non-injected control). All groups were incubated at 37°C
(A) or 25°C (B) in the dark and monitored daily for survival. Data shown are representative of at four (37°C)
or two (25°C) independent experiments. Statistical differences between survival curves were calculated
using the Log-rank test. p values; *, < 0.05; ns, difference is not significant.

4.4 DISCUSSION AND CONCLUSIONS
The unique macrocolony morphology of the Mk 13H8 mutant indicated to us that the
gene, MKAN_RS20680, disrupted by transposon insertion in this strain plays a role in the
properties of the bacterial cell surface. Although we found the disruption did not impact either
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biofilm formation or virulence in the Gm infection model, two phenotypes reasonably associated
with cell surface properties, our complementation analyses do establish a link between
MKAN_RS20680 and (macro)colony morphology. This finding represents, to our knowledge, the
first reported association of any phenotype with this gene or its orthologs in other NTM species.
As the disruption of non-essential genes involved in the biosynthesis of surface-exposed or cellenvelope associated lipids can impact multiple surface characteristics of the cell, it is attractive to
speculate that a change to one of these characteristics due to an altered lipid composition of the
outer envelope is what underpins the mutant’s phenotype. Evidence that may support a change in
one of these characteristics, surface hydrophobicity, is the apparent accumulation of red deposits,
presumably the lycopene intermediate from the beta-carotene biosynthetic pathway, on the
surface of yellow-pigmented single colonies of the mutant. While the high-level conservation of
MKAN_RS20680 within Mycobacteriaceae supports its importance to mycobacterial biology,
this conservation drops significantly in other families within Actinobacteria and little
information is available in the literature about this gene, its orthologs in other species, or its
encoded protein. The functional category of the Mtb ortholog, Rv3210c, is listed as a conserved
hypothetical (Mycobrowser: https://mycobrowser.epfl.ch/) and reported to be nonessential for in
vitro growth in the virulent H37Rv strain.64 However, it was among 194 genes required for
growth in the spleen of infected mice, potentially indicative of a role in virulence and survival in
the host, and thus attractive as a candidate for investigation.61 That the protein encoded by
MKAN_RS20680 harbors a ferritin-like domain consisting of a four-helix bundle, common in
proteins that catalyze oxidation-hydroxylation reactions, informs its enzymatic activity, but does
not provide further clues as to its biological role in Mk.
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The transposon disruption in the Mk 13D6 mutant lies 6 bp upstream of the putative
ortholog of an sRNA gene, currently nonannotated in the Mk genome, and drastically reduces its
expression close to 1000-fold. We believe this reduction leads to a strongly altered
(macro)colony morphology and a severe biofilm formation deficiency but does not affect
virulence in the Gm model host. Recent work has shed light on the phenotypic effects of
heterologous overexpression of the orthologous Mtb B11 sRNA in Ms, but to date no B11deficient mutant of any mycobacterial species has been generated. Although first detected in
Mtb, the B11 sRNA has been previously bioinformatically predicted in 12 species (including Mk
earlier this year99) and experimentally validated in two (M. bovis strain Pasteur BCG and Ms
mc215589). Our own analysis confirms and extends the conservation not only of the B11 sRNA
but of its putative promoter as well, both of which appear intact in 20 SGM and RGM species
(Figure 28). The conservation of the B11 sRNA within Mycobacteriaceae and of the 6C motif
within Actinobacteria97 suggests that the sRNA may function similarly in disparate species. That
Mk B11 is nearly identical to Mtb B11 in sequence and predicted secondary structure (Figure 20)
suggests further study of Mk B11 and the Mk 13D6 mutant may inform the role of the ortholog in
Mtb.
Our RT-qPCR analysis revealed several unexpected aspects of gene expression from the
Mk B11 locus. We noted only partially restored expression of the sRNA in the mutant when
complemented only with Mk B11-IGR. This mirrored the incomplete restoration of wt colony
morphology in Mk 13D6-R, suggesting that full restoration of B11 expression to the level of wt
would fully revert the mutant colony phenotype. Indeed, the Mk 13D6-RH strain was
characterized both by macrocolonies equivalent in appearance to wt and a level of B11
expression not significantly different from wt. As complementation of Mk 13D6 with only
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MKAN_RS12135, as in Mk 13D6-Hnative, impacted neither the (macro)colony morphology nor
B11 expression level of the mutant, it is unlikely MKAN_RS12135 or the hydrolase it encodes
plays a role in the phenotype of Mk 13D6. In view of this finding, we speculate that additional
regulatory elements present in the negative strand antisense the MKAN_RS12135 gene may be
required to generate transcripts of B11 to the level seen in the wt. However, the presence and
involvement of these putative regulatory elements in the expression of B11 and the colony
phenotypes of the mutant would not explain our observation of the wt (macro)colony
morphology shown by the Mk 13D6-RAZ complemented strain. As we demonstrate for
MKAN_12135, our RT-qPCR results show that MKAN_RS12130 expression does not
significantly differ from wt in Mk 13D6, suggesting altered expression of this gene does not
underpin the mutant phenotypes. Although we did not assess B11 expression levels in Mk 13D6RAZ, biofilm formation by this strain and Mk 13D6-RH were significantly higher than Mk 13D6R. This may reflect the possibility that B11 expression in Mk 13D6-RAZ is restored to a near wt
level, as seen in Mk 13D6-RH. As the direct involvement of MKAN-RS12130 in the mutant
phenotype appears unlikely, it may be the case that read-through transcription controlled by
multiple control elements upstream of B11 extends into the sequence encoding either
MKAN_RS12130 or MKAN_RS12125, or both, generating a transcript, later processed into the
functional 94 bp sRNA, that contributes to a transcript pool from which active B11 species are
derived. Replacement of B11-IGR strongly restored this transcript pool, but to a level
insufficient to fully restore macrocolony morphology. Addition of adjacent sequence either
upstream or downstream of B11-IGR, sufficiently restored the transcript pool and effected the
full complementation of biofilm and morphology phenotypes as observed in Mk 13D6-RH and
Mk 13D6-RAZ. Further analysis via RT-qPCR analysis and Northern blot would provide
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additional support to the above speculation by determining the existence and size, respectively,
of unique species present in the hypothesized transcript pool.
In addition to the phenotypic consequences that result from reduced expression of B11,
we establish with this study the non-essentiality of the B11 gene in Mk. This finding mirrors that
of a recent report of saturation mutagenesis in Mtb, in which all six TA dinucleotides present
either in the Mtb B11 gene or its promoter were found to tolerate transposon insertions,
demonstrating the gene is also non-essential in Mtb.
Finally, we present here the first in vivo assessment of Mk virulence in a Gm larva
infection model and show that wt Mk leads to killing at a rate comparable to that seen with other
SGM species when challenged with a comparable delivered cfu dose.113 Although our results
show that neither Mk 13H8 nor Mk 13D6 display attenuation in the Gm model, we acknowledge
assessment of the mutants in alternative infection models may yield different outcomes to reveal
roles of B11 and MKAN_RS20680 in the pathogenicity of Mk that we did not uncover here.
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(B)

SigA dependent promoter

Figure 28: Conservation of the B11 gene and promoter in 20 mycobacterial species
(A) Sequence alignment of Mtb B11, Mk B11, and predicted orthologs in other mycobacteria. (B) Sequence alignment of B11 promoter regions in
species listed in (A). Grey shading highlights identity with the Mtb sequence. Asterisks below the alignment indicate 100% conservation. The bar
under the alignment of B11 orthologs marks the sequence annotated for Mtb B11. Abbreviations to the left and chromosomal coordinates to the
right of the sequences correspond to the following bacteria and NCBI reference sequences, respectively. Mtb: M. tuberculosis strain H37Rv,
NC_000962.3; Mk: M. kansasii strain ATCC 12478, NC_022663.1; Mb: M. bovis strain AF2122/97, NC_002945; MbBCG: M. bovis BCG Pasteur
1173P2, NC_008769.1; Mm: M. marinum strain M, NC_010612.1; Mu: M. ulcerans strain Agy99, NC_008611.1; Mp: M. parascrofulaceum strain
ATCC BAA-614 SCAFFOLD1, NZ_GG770553.1; Ma: M. avium strain 104, NC_008595.1; Mc: M. columbiense strain CECT 3035,
NZ_CP020821.1; Mi: M. intracellulare strain ATCC 13950, NC_016946.1; Ms: M. sinense strain JDM601, NC_015576.1; Mab: M. abscessus strain
ATCC 19977, NC_010397.1; Mt: M. thermoresistible strain NCTC10409, NZ_LT906483.1; MJLS: M. sp. JLS, NC_009077.1; Mn: M. neoaurum
strain VKM Ac-1815D, NC_023036.2; Msm: M. smegmatis strain mc2155, NC_018289.1; Mph: M. phlei strain NCTC8151, NZ_LR134347.1; Mr:
M. rhodesiae strain NBB3, NC_016604.1; Mg: M. gilvium strain PYR-GCK, NC_009338.1; and Mv: M. vanbaalenii strain PYR-1, NC_008726.1.
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CHAPTER 5: Analysis of transposon-directed insertion site sequencing (TraDIS) data
from an M. kansasii mutant pool

5.1 INTRODUCTION
Transposon-directed insertion site sequencing (TraDIS) is a method of massively parallel
sequencing of transposon insertions (Tn-seq) that combines Tn mutagenesis and high-throughput
sequencing to analyze bacterial gene function and determine gene essentiality.135 In this method,
mutagenesis utilizing a randomly inserting transposon, such as the TA dinucleotide-specific
Himar1 present in φMycoMarT7, is first used to generate a library of hundreds of thousands of
mutants that is ‘saturated’ in that, cumulatively, the gDNA within the mutant library carries a
transposon insertion at every genomic TA site. The library is then cultured on solid agar to
generate single colonies, each representing an individual transposon mutant, that are collected
and pooled. gDNA from the pooled colonies is isolated, sheared to fragments a few hundred base
pairs in length, and adapters are ligated to the fragment ends. PCR amplification is then used to
generate a ‘DNA library’ consisting only of those adapter-ligated fragments that contain
transposon sequence. This is achieved by using primers specific to the adapter and transposon.
An additional round of PCR using nested primers follows to further enrich the library for
fragments containing transposon sequence. At this step, the primers specific to the adapter also
include sequence recognized by the next generation sequencing (NGS) platform to be used as
well as an optional ‘barcode’ sequence that enables sequence from multiple DNA libraries to be
acquired in the same run. After the sequence data is obtained, it is aligned to the target
bacterium’s genome and any TA site found not to harbor a transposon is considered likely
essential for the successful replication of that organism, presuming the size of the library is
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sufficiently large enough to be saturated beyond the threshold of probability, set for each
particular experiment, that no TA site lacks a transposon due to chance.
In addition to investigating the essentiality of genes required for simple outgrowth on
standard medium, the mutant library can be cultured under a particular growth stress, such as
exposure to a specific compound, nutrient limitation, or after injection into a host organism.
Pooled library mutants are then harvested directly from the altered in vitro conditions or from
host tissue. In each case, whether in vitro or in vivo, gDNA from the ‘input’ (pre-treatment, preinfection) and ‘output’ (post-treatment, post-infection) mutant pools is isolated and processed as
outlined in the preceding paragraph. After alignment of the sequence data to the target
bacterium’s reference genome, the TA sites found to carry transposons within each pool are
compared. If, in the gDNA taken from the output pool, a site is found not to carry a transposon, it
is reasoned that the genetic element present at that site could not tolerate transposon disruption
and is deemed essential under the conditions used.
Several gene essentiality studies reporting the use of saturation or subsaturation (i.e.
libraries in which substantially fewer than all genomic TA sites have received a transposon)
mutagenesis in mycobacteria have been described.32,60,64,136 Others have focused on the
identification of novel factors associated with a specific trait such as virulence (i.e. killing of the
host cell or organism61,137,138) or the ability to metabolize cholesterol, essential to the intracellular
replication of Mtb.62 To date, there are no reports of either type of essentiality study in Mk.
Here, we aimed to demonstrate on a small scale that Tn-seq is efficient in Mk and thus
potentially feasible for a larger study involving the generation and analysis of a saturated or nearsaturated Mk transposon library. We employed a modified TraDIS protocol to identify the
MycoMar transposon insertion sites present in gDNA isolated from a pool of ~14,700 mutants
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grown on supplemented 7H11 growth medium. Additionally, to demonstrate the utility of
TraDIS-derived data from a Mk transposon mutant library, we compared Mk ORF’s tolerant of
transposon insertion under standard in vitro growth conditions to those in Mtb reported to be
intolerant (i.e. reflect essential genes). We successfully identified roughly 12,000 insertion sites
from the pooled gDNA representing 82% of those mutants sampled and demonstrating the
robustness of this technique in Mk. Finally, we identified 17 Mk genes that received a potentially
disruptive transposon insertion for which an ortholog in Mtb was reported to be essential. While
the discrepancy in essentiality state of six of these genes between Mk and Mtb appears to be
plausibly linked to differences in the composition of media used to cultivate the two respective
libraries, the others are not clearly medium-associated and potentially suggest unique genetic
requirements of the two species. Overall, our results indicate that an expansion of this sort of
genome-wide comparison between Mk and Mtb is warranted as it would inform our
understanding of the biological basis of the evolutionary development of a professional, obligate
pathogen from an environmental-dwelling, opportunistic pathogen.

5.2 MATERIALS AND METHODS

Tn-seq experiment
Colonies of 14,693 Mk transposon mutants were scraped from supplemented Middlebrook 7H11
plates and genomic DNA was isolated from the mutant pool as described above (Section 3.2).
To identify the insertion sites in the library pool, we used a modified TraDIS-type method139,140
customized for the Himar1-based transposon in φMycoMarT7. gDNA was fragmented into 350
bp lengths and adaptor sequences were ligated to each end of the fragment using the Kapa
HyperPlus Kit (Kapa Biosystems, Inc.) as recommended by the manufacturer. Two rounds of
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optimized PCR reactions were performed to enrich for Tn-genomic DNA junction segments and
make the final PCR product compatible for Illumina sequencing. The first PCR round was done
with a Tn-specific primer (CB1) and an adapter-specific primer (IS5) for Tn-genome junction
enrichment. The second PCR round (hemi-nested) was run with the adapter-specific primer IS5
and a Tn-specific primer adding the sequences needed for Illumina sequencing and barcoding of
each sample (primer CB25.3_R or CB44.3_R). The generated fragment libraries were
sequenced on an Illumina NextSeq 500 System using a NextSeq500/550 Mid Output Kit (150
cycles; 2 x 75 cycles; paired-end reads; Illumina Inc.). Raw sequencing read data were
processed as follows: 1) Duplicate reads (same sequences for paired-end reads, considered PCR
siblings) were compressed into a single representative read; 2) Reads lacking the Tn-specific
primer sequence were discarded; 3) Reads were filtered further based on the presence of the
terminal 5 bp transposon sequence (TGTTA) adjacent to the transposon primer; 4) The primer
sequences were trimmed; 5) Each filtered and trimmed read was mapped onto the Mk
chromosome (sequence ID: NC_022663.1) and the Mk pMK12478 plasmid (sequence ID:
NC_022654.1) sequences using BLAST (https://blast.ncbi.nlm.nih.gov/BLAST).
Identification of essential M. tuberculosis gene orthologs in M. kansasii
To generate a comprehensive list of essential Mtb genes for which a corresponding list of
orthologs in Mk could be created, we compiled all ORFs determined essential by saturation
mutagenesis of Mtb. (Data provided in Supplemental Table S2 from study by Dejesus, et al.64)
Mk orthologs of essential Mtb genes were identified using BLAST and verified in the KEGG
Genes database as described above (Section 3.2).
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Selection of putatively non-essential M. kansasii orthologs of essential M. tuberculosis genes
Using our TraDIS data and parameters described by others,136 we eliminated those Mk orthologs
of Mtb essential genes carrying a transposon insertion that likely did not affect expression.
Briefly, any Mk ORFs carrying a transposon within the smaller of 20% or 100 bp from the distal
(3’) end were excluded from consideration. All remaining ORFs were considered to have been
functionally disrupted and reflect putatively non-essential Mk orthologs of essential Mtb genes
under the growth conditions used.

5.3 RESULTS

Transposon site mapping demonstrates Tn-seq is robust in M. kansasii
In the present study, we aimed to demonstrate the feasibility of combining a Himar1
transposon-based mutagenic system and high throughput sequencing of transposon insertion sites
(TraDIS) in Mk. To this end, we pooled gDNA from 14,693 Kmr colonies and detected
transposon insertions at 12,071 unique TA sites. From the sequencing data, we noted slightly
higher rates of insertion in the plasmid (16%) than in the chromosome (12%), possible
suggesting a lower number of essential genes or greater proportion of intergenic sequence in the
plasmid. Fewer essential genes may also explain the higher proportion of total genes receiving
transposon insertions on the plasmid (74%) than the chromosome (62%) (Table 3).
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Table 3: Analysis of 12,071 mapped transposon insertion sites in the M. kansasii genome
Chromosome

Plasmid

11,696

375

Total TA sites hit relative to total TA sites

12%

16%

Intragenic TA sites hit

9,573

312

Intragenic TA sites hit relative to total sites hit

82%

83%

Total genes hit

3,474

113

Genes hit relative to total annotated genes

62%

74%

Intergenic TA sites hit

2,123

63

Intergenic TA sites hit relative to total sites hit

18%

17%

Total TA sites hit

The data presented in this section is sufficient to demonstrate proof of concept that this Tn-seq
methodology is functional in Mk but is not sufficient to determine the essentiality state of genes
beyond describing those having received functionally disruptive insertions as likely to be nonessential. To be able to make gene essentiality calls, we would need a library of many more
mutants as determined by the formula below and details of the Mk genomic sequence.
The Mk genome consists of a 6,432,277 bp chromosome and a 144,951 bp plasmid.
Considering a total number of 99,953 TA sites in the combined 6.6 Mb genome, the average
distance between TA sites is 66 bp. Using the formula shown below,141 a library of around
460,000 mutants would be required for a transposon to be detected at every TA site with 99%
confidence.
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ܰ=

lnሺ1 − 0.99ሻ
lnሺ1 − ܲሻ
=
= 458,926 ݉ݏݐ݊ܽݐݑ
66
lnሺ1 − ݂ሻ
lnሺ1 − ቀ
ቁሻ
6,577,228

where f = i/g; i = average distance between TA sites (in bp); g = genome size (in bp); P =
probability.
(It should be noted here that this calculation is purely theoretical and presumes an absence of
bias for or against insertion at any particular site. The recent identification of a non-permissive
consensus sequence inhibitory to transposon insertion when present surrounding a TA site64
suggests modification of the formula may be required to maximize the accuracy of predicted
values when planning a saturation experiment.)
The high number of mutants shown reflects roughly a six-fold level of coverage of all
genomic TA sites, i.e. the library is large enough for each TA site to have been hit in six
independent mutants. This value demonstrates the extremely large library size required for a
truly saturating essentiality study and helps put into context the small number of mutants
sequenced in our pilot experiment.
We further analyzed the data to determine the number of mutants that would be required
to detect at least one transposon in every ORF:

ܰ=

lnሺ1 − ܲሻ
lnሺ1 − 0.99ሻ
=
= 27,533 ݉ݏݐ݊ܽݐݑ
1,100
lnሺ1 − ݂ሻ
lnሺ1 − ቀ
ቁሻ
6,577,228

where f = i/g; i = average gene size23 (in bp); g = genome size (in bp); P = probability.

Our sequencing data shows that, on average, we detected transposon insertions in 68% of
ORFs in the Mk chromosome and plasmid (Table 3). Based on the number of mutants predicted
above, it is estimated one would need a library of 18,722 mutants to achieve the ORF hit rate we
achieved with a smaller library of 14,693 mutants.
We acknowledge our mutant pool was considerably smaller than would be required to
saturate every genomic TA site, and this was not our aim. We simply sought to demonstrate the
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feasibility of this system in Mk and the high ratio of detected insertion sites to number of mutants
represented in the sequenced library gDNA (82%) bears that out. Our observation of a rate of
detection of intragenic transposon insertions somewhat exceeding that expected for a library of
the size we employed is an indication that the entire process from mutagenesis to bioinformatics
is robust and effective in Mk.

Non-essential M. kansasii orthologs of essential M. tuberculosis genes
From the comprehensive list of 3,587 ORFs determined in our pool of mutants to carry an
inserted transposon, we created a list (Table 4) of those that 1) are orthologous to Mtb genes
determined by saturation mutagenesis to be essential for in vitro growth and 2) carried the
transposon at a TA site that fell in a location that we predicted to disrupt the function of the gene
(See Section 5.2 for a description of how prediction of functional disruption was determined.)
Among the 17 genes we identified that fit these criteria, six encoded proteins involved in amino
acid metabolism: GcvB, GcvH, and GcvT (glycine biosynthesis and catabolism), MetE
(methionine biosynthesis), ArgA (arginine biosynthesis), and Gnd2 (pentose phosphate pathway,
general amino acid biosynthesis) (Table 4). We believe the detection of these genes among those
tolerant of transposon insertion (and thus deemed non-essential) in Mk is simply the outcome of
plating our transductant pool on Middlebrook 7H11 agar, a medium that contains an enzymatic
digest of casein and thus is replete with all amino acids. In their report of saturating mutagenesis
of Mtb, DeJesus et al. indicate plating their mutant Mtb libraries on either Middlebrook 7H10
agar or agar-solidified 7H9, two media types that each contain only glutamate and no other
amino acid. Although it has been reported that Mtb possesses the genetic potential to synthesize
all amino acids,142 it is likely that the growth of colonies of mutants carrying disruptions to the
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six genes listed above on these media was severely outpaced by those of other library mutants.
For this reason, these genes were deemed essential under the experimental conditions used. To
fully establish the essentiality of these genes, library outgrowth would need to be re-tested under
amino acid replete conditions. Our specific identification of these genes in view of the described
experimental discrepancy reinforces our conclusion that the workflow employed here is robust
and can be successfully employed in the assessment of Mk gene essentiality.
Among the remaining 11 genes identified that do not reflect clearly identifiable
methodological differences between our study and that reported by Dejesus et al. are several that
may potentially inform the disparate genetic requirements for in vitro growth of Mk and Mtb
(Table 4). Rv0286 encodes PPE4, a component of the ESX-3 system, a type VII secretion
system, that plays a role in siderophore-mediated iron uptake. PPE family proteins are unique to
mycobacteria and while 66 are encoded in the Mtb genome, Mk contains 141, potentially
indicating that the role of the PPE4 ortholog in Mk, MKAN_RS16200, is fulfilled by another
functionally redundant PPE family protein.25 Rv0824c encodes DesA1, which catalyzes
modifications to fatty acids in the biosynthesis of mycolic acids (MA), a class of essential lipids
that partially compose the outer membrane of mycobacteria.143 The reliance of Mk on the
specific MA modification catalyzed by its ortholog of DesA1, MKAN_RS10190, may not be
equivalent to that of Mtb. The exact MA composition of the outer membrane of mycobacteria
likely differ by species and MKAN_RS10190 may not be required for Mk to produce essential
MA. Additionally, Rv3802c, has been shown to have phospholipase A and thioesterase activity,
both involved in MA biosynthesis, and to be inhibited by the fatty acid synthase thioesterase
inhibitor, THL (tetrahydrolipstatin)144 and has been targeted for drug design.145 Rv1636 encodes
TB15.3, listed as an iron regulated universal stress protein. Although multiple studies have
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reported a role of TB15.3 in the response of Mtb to anti-TB drugs146,147 or other stresses such as
oxygen or nutrient deprivation,148 its exact function is unknown and it is unclear why it would be
essential in Mtb under standard in vitro growth conditions. Rv3808c encodes GlfT2, one of at
least four galactofuranosyl transferases involved in the formation of galactofuran, the cell wall
component that connects the outer MA-containing arabinan layer to the inner peptidoglycan
layer in mycobacteria.149 Essential in both Mtb and Ms,150 it is possible its ortholog in Mk is not
required due to genetic redundancy as suggested by results of a BLAST search for paralogs of
MKAN_RS13545. Together, these genes highlight differences in the gene essentiality profiles of
Mk and Mtb that may help explain the vast difference in virulence between the two pathogens.
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Table 4: Orthologs of essential M. tuberculosis genes in M. kansasii
Mtba

Mkb

Rv0286

MKAN_RS16200/
MKAN_17000

Rv0824c

MKAN_RS10190/
MKAN_10655

Rv1122

MKAN_RS07525/
MKAN_07910

Rv1133c

MKAN_RS07375/
MKAN_07725

Rv1610
Rv1636
Rv1826

MKAN_RS26640/
MKAN_27915
MKAN_RS26800/
MKAN_28080
MKAN_RS00345/
MKAN_00345

Rv1832

MKAN_RS00375/
MKAN_00380

Rv2211c

MKAN_RS02885/
MKAN_02970

Rv2511

MKAN_RS05450/
MKAN_05695

Rv2747

MKAN_RS24015/
MKAN_25150

Descriptionc

Classd

(Mtb protein name in bold)
PPE family protein PPE4
Probable acyl-[acyl-carrier protein]
desaturase DesA1 (acyl-[ACP] desaturase)
(stearoyl-ACP desaturase) (protein Des)
Probable 6-phosphogluconate
dehydrogenase, decarboxylating Gnd2
Probable 5methyltetrahydropteroyltriglutamate-homocysteine methyltransferase MetE
(methionine synthase, vitamin-B12
independent isozyme)
Possible conserved membrane protein
Iron-regulated universal stress protein family
protein TB15.3
Probable glycine cleavage system H protein
GcvH
Probable glycine dehydrogenase GcvB
(glycine decarboxylase) (glycine cleavage
system P-protein)
Probable aminomethyltransferase GcvT
(glycine cleavage system T protein)

Tn
hits

PE/PPE

1

lipid metabolism

7

intermediary metabolism
and respiration

1

intermediary metabolism
and respiration

1

cell wall and cell
processes
virulence, detoxification,
adaptation
intermediary metabolism
and respiration

1
2
3

intermediary metabolism
and respiration

7

intermediary metabolism
and respiration

2

Oligoribonuclease Orn

intermediary metabolism
and respiration

1

Probable L-glutamate alpha-Nacetyltranferase ArgA (alpha-Nacetylglutamate synthase)

intermediary metabolism
and respiration

2

MKAN_RS20345/
cell wall and cell
Probable conserved lipoprotein LpqB
MKAN_21290
processes
Hypoxanthine-guanine
intermediary metabolism
MKAN_RS11945/
Rv3624c
MKAN_12530
phosphoribosyltransferase Hpt (HGPRT)
and respiration
MKAN_RS12030/
cell wall and cell
Probable conserved transmembrane protein
Rv3645
MKAN_12635
processes
MKAN_RS13515/
cell wall and cell
Rv3802c
Probable conserved membrane protein
MKAN_14180
processes
MKAN_RS13545/
Bifunctional UDP-galactofuranosyl
cell wall and cell
Rv3808c
MKAN_14210
transferase GlfT2
processes
MKAN_RS13795/
Rv3863Δ
Unknown alanine rich protein
conserved hypothetical
MKAN_14465
Determination of Mtb gene essentiality as reported by Dejesus, et al.64; gene ID’s as listed in NCBI references
sequences: a NC_000962.3, b NC_022663.1; as provided in c NCBI and c,d Mycobrowser databases
Rv3244c
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3
2
1
1
1
2

5.4 DISCUSSION AND CONCLUSIONS
In this chapter, we have shown that TraDIS is robust in Mk and effectively identifies
transposon insertion sites following Himar1 mutagenesis. Studies utilizing similar methodologies
combining saturation mutagenesis with transposon insertion sequencing in mycobacteria are
lacking outside of Mtb and the work presented here demonstrates that such a study is feasible in
Mk. Our comparison of non-essential Mk genes (those tolerant to transposon disruption) and
genes deemed essential by saturating mutagenesis in Mtb is confounded by a discrepancy in
growth media used to cultivate the transposon libraries. The Mk genes we identified in this
comparison are nonetheless intriguing starting points to investigate differences in genetic
requirements of the two closely related species. The comparative analysis of Mk and Mtb
performed here is proof of principle that this type of study has great potential to yield leads in a
broader investigation comparing and contrasting the gene essentiality profile of these two
species.
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CHAPTER 6: Concluding remarks and future directions

The evolutionary relationship between Mk and Mtb coupled with the increasing
recognition of the medical significance of Mk and NTM infections in general suggests further
investigation into the biology of Mk is warranted. To this end, we report in this thesis the first
successful application of phage-based Tn mutagenesis to the study of Mk and associate
phenotypes with two under-characterized genes in this human pathogen. We also demonstrate
the first application of a high throughput transposon sequencing method, TraDIS, in Mk and
show that our methodology robustly identifies transposon insertion sites in a large mutant pool.
We show the φMycoMarT7 phasmid is lytic in Mk at 30°C and competent to transduce at
37°C, leading to the delivery of a single randomly inserting Himar1-based transposon and
resulting in the efficient generation of transposon mutants. Our colony morphology screen of an
arrayed library of these mutants revealed that those exhibiting altered macrocolony morphology
carry disruptions to genes disproportionately predicted by orthology to Mtb to be involved in
processes related to lipid metabolism and the cell wall.
Our analysis of two screen-identified Mk transposon mutants, Mk 13D6 and Mk 13H8,
firmly associate Mk B11, a gene encoding a conserved sRNA, and MKAN_RS20680, encoding a
conserved hydroxylase of unknown function, with (macro)colony morphology phenotypes,
respectively. We report the first multi-strain comparative assessment of biofilm formation by Mk
and show that the wt strain reliably forms biofilm microcolonies on the pegs of MBEC™ assay
plates. This system represents an experimental platform both to better understand the persistence
of this pathogen in environmental reservoirs and to test the in vitro efficacy of therapeutics that
target biofilm-associated cells. Additionally, we have demonstrated Mk 13D6 is the first biofilm-
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deficient Mk mutant and provide the first link between an sRNA and biofilm in any
mycobacterial species.
Finally, we report the use of a high-throughput transposon insertion sequencing
methodology (TraDIS) in Mk and demonstrate its robustness by identifying transposon insertion
sites in more than 80% of ~14,700 sampled mutants and finding over 12,000 unique sites,
including 9,885 within annotated ORFs, that do not impact Mk colony viability. This work
provides the first evidence that TraDIS is an effective method of genomic interrogation in Mk
and has potential not only for wider gene essentiality studies in this species, but also comparative
genome scale studies between Mk and other mycobacterial pathogens. The work presented here
not only adds significantly to the current knowledge of Mk biology, but has made available
validated, robust methodologies, a minable, arrayed Mk mutant library, and 41 phenotypic
mutants with defined genomic mutations. We feel these tools can be used to facilitate further
genomic and microbiological studies into the environmental persistence and virulence of Mk and
other pathogenic NTM.

97

SUPPLEMENTAL INFORMATION
Table S1: Mutant screening media recipes
Description of media

Ingredient

CAS ID

MW (g/mol)

Final conc.

suppl. 7H10

7H10 agar powder
Glycerol, 50%
ADN, 10X

na
56-81-5
na

na
92.094
na

19 g/L
0.50%
1X

7H11 agar powder

na

na

21 g/L

Glycerol, 50%

56-81-5

92.094

0.50%

ADN, 10X

na

na

1X

7H11 agar powder
Glycerol, 50%

na
56-81-5

na
92.094

21 g/L
0.50%

suppl. 7H11

suppl. 7H11 w/Congo red

suppl. 7H10 w/Congo red

suppl. 7H10 w/SDS

7H9 w/agarose

M63 w/agaroseb

M63 w/agarc

ADN, 10X

na

na

1X

Congo red, 1%

573-58-0

696.665

0.01%

7H10 agar powder

na

na

19 g/L

Glycerol, 50%

56-81-5

92.094

0.50%

ADN, 10X

na

na

1X

Congo red, 1%

573-58-0

696.665

0.01%

7H10 agar powder

na

na

19 g/L

Glycerol, 50%

56-81-5

92.094

0.50%

ADN, 10X

na

na

1X

SDS, 10% sterile

151-21-3

288.372

0.0085%

7H9 broth powder
Agarose
Glycerol, 50%
alternate concentrationa

na
9012-36-6
56-81-5

na
na
92.094

4.7 g/L
0.50%
0.20%
6.0%

Monopotassium phosphate, KH2PO4

7778-77-0

136.09

50 mM

Diammonium sulfate, (NH4)2SO4

7783-20-2

132.14

15.1 mM

Iron (II) sulfate heptahydrate,
FeSO4∙7H2O

7782-63-0

278.01

0.0018 mM

Agarose

9012-36-6

na

0.50%

Magnesium sulfate heptahydrate,
MgSO4∙7H2O

10034-99-8

246.48

1 mM

Glycerol, 50%

56-81-5

92.094

0.20%

Monopotassium phosphate, KH2PO4

7778-77-0

136.09

50 mM

Diammonium sulfate, (NH4)2SO4

7783-20-2

132.14

15.1 mM

Iron (II) sulfate heptahydrate,
FeSO4∙7H2O

7782-63-0

278.01

0.0018 mM

Agar

9002-18-0

na

1.50%

1 M Magnesium sulfate heptahydrate,
MgSO4∙7H2O

10034-99-8

246.48

1 mM
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Glycerol, 50%

56-81-5

92.094

0.20%

Glucose (dextrose) alternate

492-62-6

180.16

2.0%

Monopotassium phosphate, KH2PO4

7778-77-0

136.09

3.67 mM

Magnesium sulfate heptahydrate,
MgSO4 · 7H20

10034-99-8

246.48

2 mM

carbon sourced

Sauton's w/agar

ADN 10X supplement

L-asparagine
ammonium iron(III) citrate,
C6H5+4FexNyO7, 5% (w/v)
Citric acid

70-47-3

150.14

26.6 mM

1185-57-5

262.983

0.005%

77-92-9

192.12

10.4 mM

Zinc sulfate monohydrate, 1% (w/v)

7446-19-7

179.47

0.0001%

Glycerol, 50%

56-81-5

92.094

6.00%

Glucose (dextrose)

50-99-7

180.16

11.1 mM

Agar

9002-18-0

na

1.50%

Bovine serum albumin, Fraction V

9048-46-8

na

5%

Glucose (dextrose)

50-99-7

180.16

2%

Sodium chloride
7647-14-5
58.44
0.85%
Complete citation information of indicated sources for media are indicated in References section: a (Ren et al.
2007)42; b (Cortes, et al. 2010)78; c (Recht, et al. 2000)102; d (Martinez, Torello et al. 1999)49
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Figure S2: Southern blot analysis of 54 screen-identified M. kansasii transposon mutants
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Figure S2 continued
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Gel and lane ID’s refer to composite image on preceding page. Mutants yielding genomic DNA that failed to transform pir E. coli for plasmid
rescue protocol; ^ Failed insertion site sequencing analysis; * Mutant displayed consensus morphology on screen, included as control for transposon
detection. Presence of Tn in mutants 16E10 and 15A12 not confirmed. Reference ladder (loaded in first and last lanes of each gel): Roche Molecular
Weight Marker VII band sizes (bp): 8576, 7427, 6106, 4899, 3639, 2799, 1953, 1882, 1515, 1482, 1164, 992, 710, 492, 359

Table S3: Transposon insertion sites in 50 M. kansasii library mutants with altered macrocolony morphology

ORF likely
disrupted?b

Insertion
location

Genome
coordinatea

Mutant

ORF1
IDc: new (old)

Descriptiond

Mtb
orthologe

Descriptionf

Functional
categoryg

Mutants with intragenic insertions

102

16E10

3572076

ORF

ORF1

PF6

4736501

ORF

ORF1

15D4

4736443

ORF

ORF1

13H8

4736336

ORF

ORF1

3D9

2491328

ORF

ORF1

2D8

82882

ORF

ORF1

14A2

3181222

ORF

ORF1

13F5

3949008

ORF

ORF1

1G1

4028521

ORF

ORF1

16H8

4560589

ORF

ORF1

16C8

4878569

ORF

ORF1

16D10

5421266

ORF

ORF1

hydroxylase

Rv3508/
Rv3514
Rv3210c

PE-PGRS family protein
PE_PGRS54/7
Conserved protein

hydroxylase

Rv3210c

Conserved protein

hydroxylase

Rv3210c

Conserved protein

TetR family
transcriptional regulator
hypothetical protein

Rv0775

Conserved hypothetical
protein
Conserved protein

secretion protein EspK

Rv3879c

MKAN_RS17165
(MKAN_17995)
MKAN_RS17560
(MKAN_18400)
MKAN_RS19885
(MKAN_20815)
MKAN_RS21205
(MKAN_22190)

tuberculin related
protein
membrane protein

Rv0431

hypothetical protein

Rv3311

NADH dehydrogenase
subunit A

Rv3145

MKAN_RS23420
(MKAN_24535)

penicillin-binding
(lipo)protein

Rv2864c

MKAN_RS15600
(MKAN_16370)
MKAN_RS20680
(MKAN_21670)
MKAN_RS20680
(MKAN_21670)
MKAN_RS20680
(MKAN_21670)

MKAN_RS00330
(MKAN_00330)
MKAN_RS13880
(MKAN_14560)

PE family protein

Rv1823

Rv0497

ESX-1 secretionassociated protein EspK.
Alanine and proline rich
protein.
Putative tuberculin
related peptide
Probable conserved
transmembrane protein
Conserved protein
Probable NADH
dehydrogenase I (chain
A) NuoA
Possible penicillinbinding lipoprotein

PE/PPE
conserved
hypotheticals
conserved
hypotheticals
conserved
hypotheticals
conserved
hypotheticals
conserved
hypotheticals
cell wall and cell
processes

cell wall and cell
processes
cell wall and cell
processes
conserved
hypotheticals
intermediary
metabolism and
respiration
cell wall and cell
processes

Table S3 continued:
15E8

6126749

ORF

ORF1

15D5

1314990

ORF

ORF1

PG12

1719151

ORF

ORF1

14F8

2379849

ORF

1C7

2385062

PA7

103

MKAN_RS30090
(NA)
MKAN_RS05575
(MKAN_05825)
MKAN_RS07275
(MKAN_07625)

hypothetical protein

Rv1590

caiB/baiF family protein

Rv1866

secretion protein EspK

Rv3879c

NO

MKAN_RS10210
(MKAN_10675)

PstB

Rv0820

ORF

ORF1

transcriptional regulator

Rv0818

2385499

ORF

ORF1

transcriptional regulator

Rv0818

2H11

3123189

ORF

ORF1

3172520

ORF

ORF1

(2Fe-2S)-binding
protein
hypothetical protein

Rv3818

PA3
15A12

6017033

ORF

ORF1

MKAN_RS10235
(MKAN_10700)
MKAN_RS10235
(MKAN_10700)
MKAN_RS13620
(MKAN_14285)
MKAN_RS13845
(MKAN_14525)
MKAN_RS26130
(MKAN_27380)

nucleotide sugar
dehydrogenase

Rv0322

13B6

6021917

ORF

ORF1

hypothetical protein

none

15H3

380592

ORF

ORF1

polyketide synthase

Rv2048c

3A12

2766448

ORF

ORF1

MKAN_RS26150
(MKAN_27400)
MKAN_RS01700
(MKAN_01740)
MKAN_RS11945
(MKAN_12530)

Rv3624c

2E2

2839748

ORF

ORF1

MKAN_RS12255
(MKAN_12875)

hypoxanthine
phosphoribosyltransfera
se
penicillin binding
protein (membrane
carboxypeptidase:
MrcB)

15D3

3163857

ORF

ORF1

MKAN_RS13815
(MKAN_14495)

secretion protein, EspH

Rv3867

Rv3873

Rv3682

Conserved hypothetical
protein
Conserved protein

conserved
hypotheticals
lipid metabolism

ESX-1 secretionassociated protein EspK.
Alanine and proline rich
protein
Probable phosphatetransport ATP-binding
protein ABC transporter
PhoT
Transcriptional regulatory
protein
Transcriptional regulatory
protein
Unknown protein

cell wall and cell
processes

PPE family protein
PPE68
Probable UDP-glucose 6dehydrogenase UdgA
(UDP-GLC
dehydrogenase)

cell wall and cell
processes

regulatory proteins
regulatory proteins
conserved
hypotheticals
PE/PPE
intermediary
metabolism and
respiration

Polyketide synthase
Pks12
Hypoxanthine-guanine
phosphoribosyltransferase
Hpt
Probable bifunctional
membrane-associated
penicillin-binding protein
1A/1B PonA2 (murein
polymerase)

lipid metabolism

ESX-1 secretionassociated protein EspH

cell wall and cell
processes

intermediary
metabolism and
respiration
cell wall and cell
processes

Table S3 continued:

104

16H4

3168854

ORF

ORF1

15H8

3182136

ORF

NO

1E2

5277307

ORF

ORF1

3D7

5313489

ORF

ORF1

PC8

5556893

ORF

ORF1

PH8

6046113

ORF

ORF1

2H10

6121597

ORF

ORF1

15G5

6189628

ORF

ORF1

16F8

578728

ORF

15H5

2821768

15H11

MKAN_RS13830
(MKAN_14510)
MKAN_RS13890
(MKAN_14570)
MKAN_RS22885
(MKAN_23980)

type VII secretion
protein EccCa
secretion protein, espB

Rv3870

polyketide synthase
(Mas)

Rv2940c

MKAN_RS22950
(MKAN_24045)
MKAN_RS24060
(MKAN_25195)
MKAN_RS26240
(MKAN_27490)
MKAN_RS26500
(MKAN_27770)

acyl-coA synthetase

Rv2930

DNA recombination
protein RecA
acyl-coA synthetase

Rv2737c

Rv1568

MKAN_RS26820
(MKAN_28100)

adenosylmethionine--8amino-7-oxononanoate
aminotransferase BioA
ABC ATPase UvrA
(involved in NER)

NO

MKAN_RS02420
(MKAN_02480)

DNA-binding response
regulator

Rv0903c

ORF

ORF1

MKAN_RS12180
(MKAN_12785)

non-ribosomal peptide
synthase

Rv0101

2869120

ORF

ORF1

3502728

ORF

ORF1

stage II sporulation
protein E
SAM-dependent
methyltransferase

none

1G11

MKAN_RS12435
(MKAN_13060)
MKAN_RS15305
(MKAN_16060)

3H9

3680131

ORF

ORF1

MKAN_RS16020
(MKAN_16815)

membrane protein

Rv0249c

3E11

5303484

ORF

ORF1

MKAN_RS22940
(MKAN_24035)

polyketide synthase

Rv2932

Rv3881c

Rv1521

Rv1638

Rv0146

ESX-1 type VII secretion
system protein, EccCa1
Secreted ESX-1 substrate
protein B, EspB.
Probable multifunctional
mycocerosic acid
synthase membraneassociated Mas
Fatty-acid-AMP ligase
FadD26
RecA protein
(recombinase A)
Probable fatty-acid-AMP
ligase FadD25
Adenosylmethionine-8amino-7-oxononanoate
aminotransferase BioA
Probable exonuclease
ABC (subunit A - DNAbinding ATPase) UvrA
Two component response
transcriptional regulatory
protein PrrA
Probable peptide
synthetase Nrp (peptide
synthase)

cell wall and cell
processes
cell wall and cell
processes
lipid metabolism

Possible Sadenosylmethioninedependent
methyltransferase
Probable succinate
dehydrogenase
[membrane anchor
subunit]
Phenolpthiocerol
synthesis type-I
polyketide synthase PpsB

lipid metabolism

lipid metabolism
information
pathways
lipid metabolism
intermediary
metabolism and
respiration
information
pathways
regulatory proteins

lipid metabolism

intermediary
metabolism and
respiration
lipid metabolism

Table S3 continued:
16E1

5325044

ORF

ORF1

3G12

6199298

ORF

ORF1

MKAN_RS22995
(MKAN_24090)
MKAN_RS26865
(MKAN_28145)

chromosome
segregation protein Smc
hypothetical protein

Rv2922c

Probable chromosome
partition protein Smc
Conserved hypothetical
protein

cell wall and cell
processes
conserved
hypotheticals

hypothetical protein
(helicase/secretion
neighborhood CpaE-like
protein)
TetR family
transcriptional regulator
membrane protein

Rv3660c

Conserved hypothetical
protein

virulence,
detoxification,
adaptation

Rv0775

Conserved hypothetical
protein
Probable conserved
transmembrane transport
protein MmpL13b
Probable transcriptional
regulatory protein WhiBlike WhiB4
Conserved protein

conserved
hypotheticals
cell wall and cell
processes

Rv1645c

Mutants with intergenic insertions
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13D6

2810211

IGR

NO

MKAN_RS12130
(MKAN_12735)

3G11

2491713

IGR

BOTH

16F7

2349662

IGR

ORF2

MKAN_RS29570
(NA)
MKAN_RS10045
(MKAN_10490)

1D2

2837760

IGR

ORF2

MKAN_RS12250
(MKAN_12870)

WhiB family
transcriptional regulator

Rv3681c

1B2

6125527

IGR

NO

hypothetical protein

Rv1571

14C5

680123

IGR

BOTH

glycerate kinase (GlxK)

Rv2205c

13C8

1696323

IGR

NO

MKAN_RS26515
(MKAN_27785)
MKAN_RS02850
(MKAN_02935)
MKAN_RS29400
(NA)

hypothetical protein

none

Rv1146

Conserved hypothetical
protein

cell wall and cell
processes
conserved
hypotheticals
conserved
hypotheticals

Table S3 continued: Second ORF adjacent to transposon in mutants carrying intergenic insertions

Priority

coordinate

Insertion
location

ORF likely
disrupted?

13D6

1

2810211

IGR

NO

MKAN_RS12135
(MKAN_12740)

HAD-IB family
hydrolase

Rv3661

Conserved hypothetical
protein

3G11

1

2491713

IGR

BOTH

MKAN_RS10665
(MKAN_11175)

Rv0774c

Probable conserved
exported protein

16F7

4

2349662

IGR

ORF2

1D2

4

2837760

IGR

ORF2

MKAN_RS10050
(MKAN_10495)
MKAN_RS12255
(MKAN_12875)

hypothetical protein
(helicase/secretion
neighborhood CpaE-like
protein)
MarR family
transcriptional regulator
penicillin binding protein

1B2

4

6125527

IGR

NO

biotin synthase BioB

Rv1589

14C5

5

680123

IGR

BOTH

106

Mutant

ORF2
ID: new (old)

MKAN_RS26520
(MKAN_27795)

Description (NCBI)

Mtb
H37Rv
ortholog

Description
(Mycobrowser)

Functional
category
(Mycobrowser)
virulence,
detoxification,
adaptation
cell wall and cell
processes

none
Rv3682

Probable bifunctional
membrane-associated
penicillin-binding
protein 1A/1B PonA2
(murein polymerase)
Probable biotin
synthetase BioB

cell wall and cell
processes

intermediary
metabolism and
respiration
cell wall and cell
processes

MKAN_RS02855 DUF3043 domainRv2206
Probable conserved
(MKAN_02940)
containing protein
transmembrane protein
13C8
5
1696323
IGR
NO
MKAN_RS07180
hypothetical protein
none
(MKAN_07515)
a
Mk genome annotation: sequence ID: NC_022663.1; b See Section 5.2 for method of determining likelihood of functional disruption by transposon insertion; c
sequence ID: NC_022663.1(new), CP006835.1(old); d NCBI database (https://www.ncbi.nlm.nih.gov/); e sequence ID: NC_000962.3; f,g Mycobrowser database
(https://mycobrowser.epfl.ch/)

Table S4: Phenotypic assessment of screen-identified M. kansasii mutants
base medium:
solidifying agent:
additive:
b
13D6
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7H11(s)
agar

7H11(s)
agar

+++

+++

16E10
PF6
15D4
13H8
3G11b
3D9

*
*
*
*
+
++

*
*
*
*
+
++

2D8
14A2
13F5
1G1
16H8
16C8

*
*
+
*

1E9
16D10
15E8
15D5
PG12
14F8

7H10(s)
agar
Congo red
+++

7H10(s)
agar

7H9
agarose

M63
agarose

+++

7H9
agarose
Congo red
*

+++

++
++(G)
++(G)
++(G)
++
++

++
++
++
++
++
++

++
++
++
++
+
+++

+
+
+/+/*
*

+++(G)
+
+
+
+
+

+
++
+/+/*
*

++(G)
+
*
+

*
*
*
*
+++
+++

*
*
*
*
++
*

*
*
+
+/*

+
+
++
+/+

++
+
++
+/+

+
+
-

*
*
-

+++
++
-

*
*
*
*
-

++
+/++
-

*
++
*
*
*

*
*
*
*

*
*
*
*
*

*
*
*
*
*

++
-

++
+

+
++
+

*
+++

+
+++(G)
+++(G)
+/-(G)
+/-

+/+++(G)
+(G)
+/-(G)
*
-

+
++(G)
+(G)
+(G)
-

*
*
*
*
*
*

*
*
*
*
*
*

1C7
PA7
2H11
PA3
15A12
13B6

*
*
*

*
*
*

+
+
++
+

+
+
++
++

++
++

*
*
*
++
+/-

+
+
+
+++
+/-(G)
+/-(G)

*
*
*
+(G)
+

++
+/+/-

*
++
*
*

++
++
*
*
*

15H3
16F7b

*
*

*
*

+
-

+++

+
++

++

++(G)
+++

+
-

-

*
*

*
*

++

M63
agarose
6% glycerol
*

M63
Sauton’s
7H10(s)
agar
agar
agar
2% dextrose
0.0085% SDS
++
++
*
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3A12
1D2b
2E2

++
*
*

++
*
*

++
++
+

++
++
++

++
++
++

*
*
*

++
+(G)
+(G)

*
++(G)
++(G)

*
++(G)
++(G)

++
*
*

+++
*
*

15D3
16H4
15H8
1E2
3D7
PC8

*
+
*
++
*
*

*
*
+++
*
*

+/++
++
++

++
++
++

+
+
++
+/+

*
*
*
*

++(G)
+++
++(G)
++
+++(G)
+

+/*
+/*
+(G)
+(G)

+(G)
++
+(G)
++
+++
+/-(G)

*
+
*
++
*
*

*
*
*
*
*
*

PH8
2H10
1B2b
15G5
16F8
14C5b

*
*
*
*
*
-

*
*
*
*
*
-

++
+
+
++
*
-

++
++
+/++
*
-

++(G)
+
+/++
*
-

*
*
*
*
*
*

+++
+++
++(G)
*
-

++
+(G)
*
*

+++
+++(G)
+(G)
+/-(G)
*
+

*
*
*
*
*
-

*
*
*
*
*
*

15H5
15H11
1G11
3H9
3E11
16E1

*
*
*
*
*

*
*
*
*
*

*
*
*
*

*
*
*
*

*
*
*
*

*
*
*
*
*

*
*
*
*

*
*
*
*
*

*
*
*
*

*
*
*
*
*

*
*
*
*
*
*

3G12
*
*
*
b
13C8
*
*
*
*
*
*
*
*
*
*
*
(s), indicates medium was supplemented with 1X ADN; (+++,++,+), intensity of observed deviation from Mk wt colony morphology on same medium; (-), mutant
displayed Mk wt colony morphology; (*) not plated or contamination obscured analysis; (G), growth defect observed relative to Mk WT; (boxed), medium used to
identify mutant in screen; a Name of annotated Mk gene (or identifiable Mtb ortholog) hit by transposon, if available; b Intergenic transposon insertion

Table S5: M. kansasii strains generated for complementation study
Strain

Description

Mk WT-v

Mk ATCC 12478 (wt) + pML-ΔxylE

Mk 13D6-v

Mk WT carrying the transposon from the φMycoMarT7 phasmid directly upstream of the
putative homolog of the Mtb sRNA ncRv13660c (“B11”) + pML-ΔxylE

Mk 13D6-R

Mk 13D6 transposon mutant carrying pML-WCB4 at the L5 attB phage integration site.

Mk 13D6-RH

Mk 13D6 transposon mutant carrying pML-WCB4.1 at the L5 attB phage integration site.

Mk 13D6-RAZ

Mk 13D6 transposon mutant carrying pML-WCB4.2 at the L5 attB phage integration site.

Mk 13D6-Rtad

Mk 13D6 transposon mutant carrying pML-WCB4.3 at the L5 attB phage integration site.

Mk 13D6-RtadH

Mk 13D6 transposon mutant carrying pML-WCB4.4 at the L5 attB phage integration site.

Mk 13D6-Hhigh

Mk 13D6 transposon mutant carrying pML-WCB2.1 at the L5 attB phage integration site.

Mk 13D6-Hnative

Mk 13D6 transposon mutant carrying pML-WCB2.2 at the L5 attB phage integration site.

Mk 13H8-v

Mk WT carrying the transposon from the φMycoMarT7 phasmid within the
MKAN_RS20680 ORF + pML-ΔxylE

Mk 13H8-HXhigh

Mk 13H8 transposon mutant carrying pML-WCB2h at the L5 attB phage integration site.

Mk 13H8-HXnative

Mk 13H8 transposon mutant carrying pML-WCB4h at the L5 attB phage integration site.
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Table S6: Mycobacterial complementation vectors used in the study
Plasmid

Description of features and construction

Size (bp)

Origin

110

pML1335

pML1342 backbone, psmyc-gfpm2+

6,484

Huff et al., 2010114

pML1335WCB1

pML1335 backbone; xylE + RBS (ScaI/NotI fragment, 944 bp) replaced with the PCR
amplicon (383 bp) generated from primers CB3 and CB4 encompassing Mk genome
from nt 2809862-2810208 (Mk B11 and downstream IGR); After TOPO-cloning and
sequencing, insert (370 bp) excised from TOPO vector with ScaI/NotI and ligated into
open host vector (5,541 bp), regenerating ScaI and NotI sites and adding PsiI, SnaBI,
and BstBI sites

5,911

this study

pML1335WCB2

pML1335 backbone; xylE + RBS + pwmyc (BspHI/BspHI fragment, 1,313 bp;
BspHI/NotI, 20bp) replaced with the PCR amplicon (452bp) generated from primers
CB3 and CB5 encompassing Mk genome from nt 2809862-2810208 (Mk B11 and
downstream IGR); After TOPO-cloning and sequencing, insert (441 bp) excised from
TOPO vector with BspHI/NotI and ligated into open host vector (5150 bp), placing
MOPΔ upstream of Mk B11, regenerating BspHI and NotI sites, and adding PsiI,
SnaBI, and BstBI sites

5,591

this study

pML1335WCB3

pML1335 backbone; xylE + RBS + pwmyc (BspHI/NotI fragment, 1,313 bp;
BspHI/NotI, 20 bp) replaced with the PCR amplicon (417 bp) generated from primers
CB3 and CB6 encompassing Mk genome from nt 2809862-2810242 (Mk B11 with
putative promoter and downstream IGR); After TOPO-cloning and sequencing, insert
(406 bp) excised from TOPO vector with BspHI/NotI and ligated into open host vector
(5150 bp), regenerating BspHI and NotI sites, and adding PsiI, SnaBI, and BstBI sites

5,556

this study

Table S6 continued:

5,689

this study

pML1335ΔxylE

pML1335-WCB2 backbone; Mk genomic sequence with sRNA and downstream IGR
eliminated following PsiI and SnaBI digestion and blunt-end recircularization; PsiI and
SnaBI sites are lost.

5,238

M. Farhat
(Quadri Lab)

pML1335WCB4.1

pML1335-WCB4 backbone; Mk genomic sequence (BspHI/SnaBI fragment, 528 bp)
replaced with the PCR amplicon (1,475 bp) generated from primers CB3 and CB17
encompassing Mk genome from nt 2809862-2811283 (Mk B11-IGR and hydrolase);
After TOPO-cloning and sequencing, insert (1,453 bp) excised from TOPO vector with
BspHI/SnaBI and ligated into open host vector (5,161 bp), regenerating BspHI and
SnaBI sites, and adding the tttrpA+ terminator114

6,614

this study

pML1335WCB4.2

pML1335-WCB4 backbone; Mk genomic sequence (BspHI/SnaBI fragment, 528 bp)
replaced with the PCR amplicon (2,832 bp) generated from primers CB7 and CB15
encompassing Mk genome from nt 2807566-2810381 (Mk B11-IGR,
MKAN_RS12130/tadZ, and MKAN_RS12125/tadA); After TOPO-cloning and
sequencing, insert (2,824 bp) excised from TOPO vector with BspHI/SnaBI and
ligated into open host vector (5,161 bp); BspHI and SnaBI sites are regenerated

7,985

this study

pML1335WCB4.3

pML1335-WCB4 backbone; Mk genomic sequence (BspHI/SnaBI fragment, 528 bp)
replaced with PCR amplicon (5,039 bp) generated from primers CB7 and CB16
encompassing Mk genomic sequence from nt 2805359-2810381 (Mk B11-IGR,
MKAN_RS12130/tadZ, MKAN_RS12125/tadA, MKAN_RS12120/tadB,
MKAN_RS12115/tadC, MKAN_RS12110/flp1, MKAN_RS12105/tadE, and
MKAN_RS12100/tadF); After TOPO-cloning and sequencing, insert (5,031 bp)
excised from TOPO vector with BspHI/SnaBI and ligated into open host vector (5,161
bp); BspHI and SnaBI sites are regenerated

10,192

this study

111

pML1335WCB4

pML1335 backbone; xylE + RBS + pwmyc (BspHI/NotI fragment, 1,313 bp;
BspHI/NotI, 20 bp) replaced with the PCR amplicon (550 bp) generated from primers
CB3 and CB7 encompassing Mk genome from nt 2809682-2810381 (Mk B11-IGR);
After TOPO-cloning and sequencing, insert (539 bp) excised from TOPO vector with
BspHI/NotI and ligated into open host vector (5,150 bp), regenerating BspHI and NotI
sites, and adding SnaBI and BstBI sites

Table S6 continued:

pML1335WCB4.4

pML1335WCB2.1

112

pML1335WCB2.2

pML1335WCB4h

pML1335WCB2h
Δ

pML1335-WCB4 backbone; Mk genomic sequence (BspHI/SnaBI fragment, 526 bp)
replaced with PCR amplicon (5,964 bp) generated from primers CB16 and CB17
encompassing Mk genomic sequence from nt 2805359-2811283 (Mk B11-IGR,
MKAN_RS12135/ hydrolase, MKAN_RS12130/tadZ, MKAN_RS12125/tadA,
MKAN_RS12120/tadB, MKAN_RS12115/tadC, MKAN_RS12110/flp1,
MKAN_RS12105/tadE, and MKAN_RS12100/tadF); After TOPO-cloning and
sequencing, insert (5,954 bp) excised from TOPO vector with BspHI/SnaBI and
ligated into open host vector (5,163 bp); BspHI and SnaBI sites are regenerated
pML135-WCB2 backbone; Mk genomic sequence and MOP (BspHI/NotI fragment,
441bp) replaced with the PCR amplicon (1,041 bp) generated from primers CB41 and
CB17.1 encompassing Mk genome from nt 2810368-2811251
(MKAN_RS12135/hydrolase); After TOPO-cloning and sequencing, insert (1,030 bp)
excised from TOPO vector with BspHI/NotI and ligated into open host vector (5,150
bp), regenerating the BspHI and NotI sites, and adding an optimized RBS, MOP, and
the T4g32 terminator151
pML135-WCB2 backbone; Mk genomic sequence and MOP (BspHI/NotI fragment,
441 bp) replaced with the PCR amplicon (1,162 bp) generated from primers CB42 and
CB17.1 encompassing Mk genome from nt 2810178-2811251
(MKAN_RS12135/hydrolase with putative native promoter); After TOPO-cloning and
sequencing, insert (1,151 bp) excised from TOPO vector with BspHI/NotI and ligated
into open host vector (5,150 bp), regenerating the BspHI and NotI sites, and adding the
ttsbiA terminator114
pML1335-WCB4 backbone; Mk genomic sequence (BspHI/SnaBI fragment, 526 bp)
replaced with PCR amplicon (819 bp) generated from primers CB12 and CB14
encompassing Mk genomic sequence from nt 4736036-4736842
(MKAN_RS20680/hydroxylase with putative native promoter); After TOPO-cloning
and sequencing, insert (813 bp) excised from TOPO vector with BspHI/SnaBI and
ligated into open host vector (5,163 bp); BspHI and SnaBI sites are regenerated
pML1335-WCB2 backbone; Mk genomic sequence (BspHI/PsiI fragment, 353 bp)
replaced with PCR amplicon (745 bp) generated from primers CB13 and CB14
encompassing Mk genomic sequence from nt 4736124-4736842
(MKAN_RS20680/hydroxylase); After TOPO-cloning and sequencing, insert (739 bp)
excised from TOPO vector with BspHI/PsiI and ligated into open host vector (5,238
bp), placing MOP upstream of hydroxylase, regenerating BspHI and SnaBI sites

MOP sequence is bracketed by BspHI and PsiI sites for downstream removal

11,117

this study

6,180

this study

6,301

this study

5,976

this study

5,977

this study

Table S7: Primers used in the study
Cloning primers
Primer
name

Amplicon
(bp)

CB3

[multiple]

CB4

WCB1
(383)

CB5

WCB2
(452)

CB6
CB7

113

CB17
CB15
CB16
na

WCB3
(417)
WCB4
(550)
WCB4.1
(1,475)
WCB4.2
(2,832)
WCB4.3
(5,039)
WCB4.4
(5,964)

sequence (5’→3’)
ATGCGGCCGCTTCGAATACGTATCATCATCGCCAACAC
TCCGGGACCAAGGGT
CGAGTACTTTATAACATTACCGGCCTAGAGCCGAGGG
TGCATCAGCCCG
GATCATGAAGACCCCAGGCTTGACACTTTATGCTTCCG
GCTCGTATAATGTGTGGAATTGTGAGCGCTCACAATTC
GTTATAACATTACTCGGCCTAGAGCCGAGGGTGCATC
AGCCC
GATCATGATTATAATTGCGTGAATGCCATCTGGCATGT
GTATAGTAAGCA
GATCATGAGGACGGTCACCAATCAAGCATAGGT
GATCATGAAAAAAAAAGCCCGCCATTAGGCGGGCTGA
CGATTGGTGAAACTGGGACACCA
ATTACGTACGATGGGGACGTAAGACCTG
ATTACGTAGGGTTGACGTAGCGGTTCA
na

Genomic location (F/R relative to
published genome)
(F) 5’ end MKAN_RS12130 (tadZ)

Features
NotI, BstBI,
SnaBI

(R) 5’ end Mk-B11;
pairs with CB3

ScaI, PsiI

(R) 5’ end Mk-B11;
pairs with CB3

BspHI, MOP,
PsiI

(R) upstream of 5’ end Mk-B11;
pairs with CB3
(R) 5’ end MKAN_RS12135 (hydrolase);
pairs with CB3
(R) 3’ end MKAN_RS12135 (hydrolase);
pairs with CB3
(F) 5’ end MKAN_RS12120 (tadB);
pairs with CB7
(F) 3’ end MKAN_RS12100 (tadF);
pairs with CB7
CB16 pairs with CB17

BspHI, PsiI
BspHI
BspHI, tttrpA+
SnaBI
SnaBI
na

(R) 3’ end MKAN_RS12135 (hydrolase)

NotI

(F) 5’ end MKAN_RS12135 (hydrolase);
pairs with CB17.1

BspHI, T4g32,
MOP, RBS

WCB2.2
(1,162)

GAGCGGCCGCGACGATTGGTGAAACTGGGACACCAGT
GCCGCA
GATCATGAGGGGACCCTAGAGGTCCCCTTTTTTAGACC
CCAGGCTTGACACTTTATGCTTCCGGCTCGTATAATGT
GTGGAATTGTGAGCGCTCACAATTCGCAACCTGAGGA
AAATTGATGACCGTCCCCGACCCGGCTGCCCA
GATCATGAAAAAAAAAAAGCCCCGCGATTGCGGGGCT
TTTTTTTTTTGATGCACCCTCGGCTCTAGGCCGA

[multiple]

TACGTATGCACTCGCTGACAGCGGTCA

(R) 3’ end MKAN_RS20680 (hydroxylase)

CB17.1

[multiple]

CB41

WCB2.1
(1,041)

CB42
CB14

(F) 5’ end Mk-B11;
pairs with CB17.1

BspHI, ttsbiA
SnaBI

Table S7 continued:
CB12

WCB4h
(819)

TCATGAAACAGCACAGATCCAGCCACTACCA

CB13

WCB2h
(745)

TTATAACGGCGAGAGGAAAGTTGCCATGACTTCGCCC
ACA

(F) intergenic region between
MKAN_RS20675 (DEAD/DEAH box
helicase) and MKAN_RS20680
(hydroxylase);
pairs with CB14
(F) 5’ end MKAN_RS20680 (hydroxylase);
pairs with CB14

BspHI

PsiI, opt-RBS

Southern blot probe primers
Primer
name
GG1
GG2

Amplicon
(bp)
512

sequence (5’→3’)

Location (F/R relative to
transposon sequence:
AF411123.1)

GACTGGCTGCTATTGGGCGAAG

(F) 5’ end aph cassette

AGAAGGCGATAGAAGGCGATG

(R) 3’ end aph cassette

Probe coordinates

1467-1978

RT-qPCR primers
114

Primer
name

Amplicon
(bp)

CB10
CB11
CB8c
CB9c3
CB49a
CB50a
CB43a
CB44a

sigA
(135)
Mk B11
(100)
tadZ
(104)
hydrolase
(115)

Sequence (5’→3’)
GGCCAGCCCCGTACTCTCGAC
ATCCAGGTAGTCGCGCAGGACT
CATTACTCGGCCTAGAGCCGAGGGTGCATC
AAAAGGGACGACCCCCGCCAGGG
CGCCGACCTCGTTGTCCTGGTCT
CCAGCCCCAGGTTGGGGTTGA
GCGCGGTTGGCAGGTGTTGTCATT
GGCCAGCGCACTGACTCCCA

Genomic location (F/R relative
to ref. genome)
(F) 3’ end MKAN_RS24220
(R) 3’ end MKAN_RS24220
(F) 3’ end ncMKAN_RS112130Ac
(R) 3’ end ncMKAN_RS112130Ac
(F) 3’ end MKAN_RS12130
(R) 3’ end MKAN_RS12130
(F) 3’ end MKAN_RS12135
(R) 3’ end MKAN_RS12135

Amplicon coordinates
(RefSeq: NC_022663.1)
5589258-5589392
2810109-2810208
2809046-2809149
2811070-2811184
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